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Abstract
Allergic diseases are distributed worldwide and their risk factors and triggers vary according to geographical and
socioeconomic conditions. Allergies are frequent in the Tropics but aspects of their prevalence, natural history, risk
factors, sensitizers and triggers are not well defined and some are expected to be different from those in temperate
zone countries. The aim of this review is to investigate if allergic diseases in the Tropics have particularities that deserve
special attention for research and clinical practice. Such information will help to form a better understanding of the
pathogenesis, diagnosis and management of allergic diseases in the Tropics. As expected, we found particularities in the
Tropics that merit further study because they strongly affect the natural history of common allergic diseases; most of
them related to climate conditions that favor permanent exposure to mite allergens, helminth infections and stinging
insects. In addition, we detected several unmet needs in important areas which should be investigated and solved by
collaborative efforts led by the emergent research groups on allergy from tropical countries.
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Background
Allergy is an ecosystem determined disorder and variations
in risk factors and triggers in different places is a common
finding. These variations can be grouped into two major
geographical environments that influence the evolution of
allergic diseases: temperate zones and the Tropics. Now-
adays most of theoretical foundations of allergy are derived
from studies in temperate zones but important emerging
information from the Tropics is showing that there are
peculiarities in the natural history of allergies that deserve
more systematic studies, not only for scientific reasons but
also for designing strategies to improve the management
and prevention of these disorders.
In general, the prevalence of allergic diseases in the
Tropics is as high as is observed in temperate countries
and in some regions even higher; however, food allergies
and especially peanut allergy seem to be less common. It
is essential to know the particular and shared risk and
protective factors in order for the scientific community be
able to stop the current allergy epidemic. Several risk fac-
tors for allergic diseases in the Tropics are similar to those
in temperate zones but important exceptions justify par-
ticular analyses. One of the most striking epidemiologic
differences is the perennial co-exposure to house dust
mites (HDM) inhalation and helminth infections. The im-
pact of this context on the inception, expression, evolution
and management of most allergic diseases is increasingly
understood but basic and clinical research is still needed
to have a more accurate view of the natural history of al-
lergic diseases in the Tropics.
As allergies that are highly dependent on environmental
factors, it is expected that exposure to native (and some-
times exclusive) allergenic sources contribute to a high pro-
portion of the differences. However, there are other less
evident conditions that could modify allergy phenotypes in
the Tropics. The effects of parasitic infections and the
microbiota composition, which involve more complex
mechanisms that potentially alter the allergic responses
even to the conventional inducers, are examples of these
conditions. In addition to specific tropical conditions, the
urban centers of the Tropics share several risk factors such
as air pollution and culturally-unique dietary patterns.
Because some of the current particularities in the Tro-
pics are the result of limited hygiene conditions, it could
be said that when future sanitary standards become the
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same as in the industrialized world, the differences would
be determined basically by genetic factors, differences in
microbiota due to natural climate and biodiversity, and
currently unknown factors influencing the immune re-
sponses in the Tropics. In this review we present and
analyze the results of a comprehensive search of the inter-
national and regional scientific databases, looking for those
aspects of allergy in the Tropics that, based on scientific
evidence, could be considered different from those ob-
served in places with temperate climates. The literature
search was conducted mainly in Pubmed and the search
terms were selected according to the topics, for example,
“asthma symptoms” and “allergen sensitization”. These
were combined with “”tropical climate” or “tropics”, “Asia”,
“Africa”, “South America”, etc. MeSH terms were also used
and limited, for example, to “humans”, “English language”,
etc. Most searches were accessed during 2015. The search
results were then reviewed and selected based on basic, epi-
demiological or clinical relevance and studies done in the
tropical and subtropical regions. The investigation was
done to provide updated information to investigators and
clinical practitioners and to evaluate the following hypoth-
eses: a) Allergic diseases in the Tropics have particularities
that deserve systematically designed studies and description
in order to detect unmet research needs and provide better
management of patients in the Tropics. b) Most of the par-
ticularities are related to climate conditions that favor the
permanent exposure to mite allergens, helminth infections
and stinging insects.
The Tropics: particular climate and socio economic
conditions influencing allergy
Climate and biodiversity
The Tropics (Torrid Zone) is one of the most dynamic
and interesting regions of the world and contains the
largest collection of living plants and animal species. The
historical view that inhabitants from the temperate zone
had about the Tropics has changed from not suitable for
civilized habitation to being a paradise that harbors most of
planet’s biodiversity which should be protected for the sake
of humanity. For example, the Amazon rainforest covers
most of the Amazon Basin of South America and com-
prises the largest and most biodiverse tract of tropical
rainforest worldwide. In the past, most of the current
tropical countries were colonies, mainly of European
countries. During those times, the ancient view of the Tro-
pics as a place of pestilences was reinforced by reports
from physicians and scientists of particular (exotic) infec-
tious diseases that were the foundations of “tropical medi-
cine”. This concept is so strongly linked to infections that
the study of other types of diseases, such as allergic dis-
eases, had been delayed until several pernicious pre-
conceived ideas were surpassed. Mean annual temperature
in the Tropics is 28 °C and relative humidity 85 %. These
conditions favor the existence of house dust mites and in-
testinal helminth infections, two of the most important
environmental components of allergic diseases in the Tro-
pics. In general, the temperate zone has moderate climate
and four seasons but there are variations such as oceanic,
Mediterranean and hemiboreal climates. In the Tropics
there are also places of high altitudes where the climate is
not typically hot and humid. These internal geographical
variations in both zones could be the source of epidemio-
logical differences, but in this review each zone will be
taken as a whole.
Cultural beliefs and "folk medicine"
In tropical countries high rates of uncontrolled asthma
and other allergies are frequently observed [1, 2], which
is related to the particularities in perception and cultural
attitudes towards disease, as well as education and socio-
economic conditions. The use of folk medicine (also
known as traditional or indigenous medicine) to alleviate
symptoms of asthma is well-accepted among different
tropical cultures, but one concern about disease manage-
ment with this type of medicine is that it reduces adher-
ence to allopathic drugs that have been scientifically tested
for allergic symptoms. While this theme has not been suf-
ficiently addressed, there are many reasons to think that
the poor use of the optimal treatment for allergic diseases
has a socio-economical origin rather than a cultural pref-
erence of folk medicine by people living in the Tropics.
Studies about cultural beliefs regarding asthma in "La-
tino" communities show the co-existence of the biomed-
ical model and ethnocultural beliefs to explain disease.
Closeness to allopathic medicine is dependent on access
to the health system, with the poorest being more at-
tached to alternative options for treatment and health at-
tention [3]. Qualitative research conducted in Latino
communities also suggests that, in spite of using folk medi-
cine products, parents or caregivers do not replace allo-
pathic drugs for asthma treatment [4, 5]. In contrast,
Bearison et al. found that, for Puerto Ricans, for example,
reliance on home remedies for asthma is related to poor
adherence with prescribed regimens [6].
Unawareness of disease and disease severity
An initial obstacle to accessing medication is the unaware-
ness of being sick. Different studies in Latin America, for
example, have found that most allergic conditions are fre-
quently underdiagnosed [7]. In this sense, many people live
with airflow limitation (and impaired qualify of life) but do
not receive the appropriate treatment. Lack of information
about allergic problems is expected in poor countries [8].
On the other hand, in different areas of the Tropics, patient
perceptions of the severity of their own symptoms is far
from reality [2]. In a recent multi-national survey in
Latin America, Maspero et al. found that although 60 %
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of asthmatic patients reported their disease as well or
completely controlled, a minority of them (8 %) met
guideline criteria for well-controlled asthma [9]. The use
of inhaled corticosteroids among patients with persistent
asthma is scarce, which is related to the perception of dis-
ease as an acute condition only [10]. Another survey about
asthma insights and attitudes, performed in 8 Asian-
Pacific countries, found similar results to those in Latin
America. Although the reasons are not well-defined it is
possible that cultural beliefs and perceptions about disease
origin may influence these findings. In Taiwan, for ex-
ample, 76 % of surveyed patients admitted to having fear
of inhaled steroids [11]. It is important to highlight that
problems about perception of disease severity are not
restricted to the Tropics and reinforcement on education
about asthma control is a global need [12], but pertinent
causes in each region must be identified.
Socio-economic conditions
There are 144 countries partially or fully located in Torrid
Zone, comprising around 40 % of human beings. With the
exception of Singapore and Hong Kong, most places are
underdeveloped, with low or middle income economies
where urbanism grows parallel to social inequalities.
Urbanization is not always well planned but often guided
by social problems in which rural inhabitants move to
large urban centers. Although hygiene has improved in
some cities, in general the poverty levels and low quality
health policies impede the progress toward better hygiene
conditions. In addition, in the bigger urban settings delin-
quency and violence induce behavioral changes among
the population, especially the time spent indoors.
Poverty has a negative impact for asthma development
and management [13, 14]. Elevated rates of uncontrolled
asthma are found among the poorest [15]. Chronic
asthma represents important out of pocket expenditures
for families since access to health system is not universal,
even though equality is the ultimate goal in health policies
for most countries [16]. Moreover, control drugs for
asthma are not easy to get in several countries. Beta-2
agonist inhalers are the “control” drug for many non-
informed patients. Consequently, avoidable episodes of
asthmatic crisis are frequent, and in turn, emergency
room attendance rates are also high. Ultimately, the
restrictions in expenditure for asthma management gener-
ates greater direct costs for the health system than those
generated by providing free medication to uncontrolled
patients or creating medical programs for asthma control
and education. In countries where important changes in
health policies about asthma management have been in-
troduced, a dramatic reduction in asthma morbidity and
mortality has been observed [17, 18]. High rates of uncon-
trolled asthma and other allergies and their underlying
factors should be considered when classifying these
problems during clinical and epidemiological surveys be-
cause they could be important confounding factors.
In summary, the climate, cultural and socioeconomic
conditions in the Tropics facilitate an environment for
the development of allergic diseases. Although socioeco-
nomic conditions and particularly hygiene are modifiable
risk factors, temperature and humidity levels are more
constant and very appropriate for mite growth. The con-
sequence of mite allergen exposure throughout the year
is, probably the most important particularity of the Tro-
pics with regards to allergy.
The natural history of allergic disorders in the Tropics
The natural history of disease refers to its progression in
an individual over time, in a course that involves stages
of susceptibility, subclinical disease, clinical disease, and
a final phase of recovery/remission, disability or death.
Since the inception of allergy is largely dependent on the
ecology and environmental effects, it is expected to find
a broad diversity of predisposing and aggravating factors
around the world. Studies in temperate areas often report
that allergic diseases are more frequent in children with
parental antecedents of atopy. Patients first develop cuta-
neous symptoms early in life, in the context of IgE
sensitization to food allergens and aeroallergens, and then
have respiratory symptoms in late childhood. They are also
more frequent in children with early wheezing in the con-
text of atopic sensitization. There is a male predominance
that equilibrates gradually during childhood and cessation
of symptoms is common but less likely if two allergic phe-
notypes co-exist (e.g. asthma and eczema) [19, 20].
Recent studies on patient phenotyping using biomarkers
and clustering analyses have made it evident that there are
many disease endotypes [21] and indeed more than one
“natural history”, with environmental effects as major con-
tributors and acting on a permissive genetic background.
The problem of defining the natural history of allergy is not
exclusive of the Tropics; in fact, the information available in
temperate and industrialized countries is not enough to
make accurate conclusions. Understanding the natural his-
tory will help to control the increasing trend of allergy
prevalence, especially in tropical places, where asthma is
also becoming a public health problem. As stated by The
Global Asthma Report 2014: “The historical view of asthma
being a disease of high-income countries no longer holds,
most people affected are in low- and middle-income coun-
tries, and its prevalence is estimated to be increasing fastest
in these countries” (http://www.globalasthmarepor-
t.org/burden/burden.php). Given the remarkable differ-
ences between tropical and temperate areas, certain
environmental triggers and risk factors have particular
relevance in the inception and progression of allergic
diseases in the Tropics, as well as in defining the strat-
egies for diagnosis and treatment [22].
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Different phenotype paths
The tropical climate is among the particular factors that
may influence the natural history of allergy. In this re-
gion of the world there are periods of the year with and
without rain (dry season) [23] but not seasonal varia-
tions as described in temperate areas [24]. The high
humidity is reflected in a high number of house dust
mites, cockroaches, and molds and therefore a higher
allergen load in homes and bedding materials. The rainy
season is related to acute exacerbations of asthma by
rapid changes to cold temperatures, the effects of thun-
derstorms on aerobiology or by promoting outbreaks of
respiratory viral infections [25, 26]. Moreover, in regions
with high temperatures, high humidity and rainfall
through the year, the exposure to home dampness and
molds in indoor bedrooms increases the risk for current
symptoms of rhinoconjunctivitis [27]. Poor ventilation in
indoor bedrooms is common, especially in deprived
areas [28]. In some regions and because of the high
temperature, windows and doors are open most of the
time, and some studies revealed that in those settings
natural ventilation is a protective factor for asthma [29].
The climate also predisposes to insect bites that induce
papular urticaria.
As occurred in developed countries a few decades ago,
urbanization seems to be critical in modifying allergic
susceptibility, as suggested by the fact that prevalence of
allergic diseases in urban and sub-urban areas of the
Tropics are comparable to those found in affluent
countries, but are very low or non-observed in rural
communities [30–33]. Urbanization has a deep impact
on the type of housing and bedding, access to green
areas, diet, quality of water and air and exposure to
pollutants. It should be pointed out that in many trop-
ical areas urbanization often occurs in the context of
poverty, and this combination promotes the exposure
to noxious agents, fungal spores, and obsolete or low
quality products that are regulated or even forbidden
in the developed world, but modify allergy risk and
promote reactions to nickel, cosmetics, detergents,
rubber and pesticides in tropical settings [34, 35]. Wealth
is also an important risk factor because even within short
geographical distances the prevalence of IgE sensitization
to aeroallergens is significantly higher in urban communi-
ties of high income compared to those economically
deprived [36].
A remarkable finding is the high prevalence of recurrent
wheezing in several tropical countries, compared to Europe
and USA. Diverse viruses have been detected in children
suffering acute respiratory illnesses in the Tropics [37].
Lower respiratory tract infections by respiratory syncytial
virus cause 27 to 96 % of all acute wheezing hospitalizations
in children under 6 month of age [38], and human
rhinovirus is the most common pathogen in children
with asthma and viral wheeze [39, 40]. In temperate
areas, viral infections are also a frequent cause of wheez-
ing but in tropical countries the admissions to hospitals
are more frequent and the episodes more severe (http://
www.globalasthmareport.org/burden/burden.php), [41]. In
some tropical regions the viral-induced exacerbations of
asthma are independent on the time of the year [42]. The
oropharyngeal microbiome appeared to contain many
more Streptococci in infants of rural Ecuador compared to
Western Europe and the USA, and comparisons between
healthy and wheezing children revealed significant differ-
ences in several bacterial phylotypes [43].
The few longitudinal studies analyzing the trajectories
of allergic symptoms in the Tropics revealed particular
aspects in the expression of allergic phenotypes. One
remarkable finding is that the timeline in which IgE
sensitization and symptoms evolve in the Tropics differs
to the atopic march that has been described in some
industrialized countries [44]. In the atopic march the
symptoms often appear in a particular sequence starting
with atopic dermatitis (AD) as the first manifestation of
allergy in an infant, followed by food allergy, seasonal or
perennial allergic rhinitis and finally asthma at late
childhood [45]. Approximately 40-70 % of children with
AD outgrow the disease by age 7 years but about half of
them develop a respiratory allergy later in life [19]. In
the Tropics, an observational study in the birth cohort
FRAAT (Risk Factors for Asthma and Atopy in the Tro-
pics), conducted in Cartagena (Colombia), revealed that
none of children in the follow-up developed AD during
the first two years of age, but 38 % of them have had
wheezing and 15 % were recurrent wheezers [46]. Similar
findings were obtained by a prospective study in Campinas
(Brazil) in which 31 % of children at 12 months of age have
had two or more wheezing episodes but there was only one
case of AD [47]. The Ecuavida birth cohort in Esmeraldas
(Ecuador) reported that 2.5 % of children by age 3 years
have had recurrent episodes of eczema but 25.9 % have had
wheezing and 7.1 % recurrent wheezing [48]. From those
studies we can conclude that in some areas of the Tropics
the dynamics of allergic manifestations is skewed to debut
with respiratory symptoms. However, it is worth mention-
ing that birth cohorts in Malaysia [49] and Taiwan [50] have
found that timelines for allergic symptoms in early child-
hood proceed according to the atopic march of temperate
areas, suggesting that depending on the genetic background
and the socioeconomic setting, the natural history can
largely differ even within tropical regions. The concept of
atopic march is controversial, and it has been recently
described that only 7 % of children follow trajectories that
resemble this pattern [51]. Since very few longitudinal stud-
ies have prospectively followed the evolution of allergic
phenotypes in the same individuals, most conclusions on
the natural history have been derived from cross-sectional
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studies. More studies considering careful phenotype assess-
ment, bias in sample selection and heterogeneous exposure
to infectious agents are highly needed. The following points
could summarize the particularities in the natural history of
allergic conditions in the Tropics. All of them will be
further analyzed in each section of this review.
 Early respiratory symptoms are more frequent than
AD in children. The reason is still unclear but
perennial mite exposure, early helminthic infections
and genetic factors may play a role.
 In general, there is a low prevalence of
physician-diagnosed AD, varying from infrequent
or non-observed in some places to common in
others. Remarkable differences in AD prevalence
can be observed even in the same country.
 Allergic skin reactions do occur in the Tropics and
in general are the same as in temperate countries,
but in some regions they show remarkable
differences regarding to clinical presentation and
risk factors [52]. Parasite migration or treatment
with antiparasitic drugs can induce urticaria.
 Papular urticaria by insect bites is more common
than in the rest of the world.
 Early exposures to geohelminths infections modify
the expression of allergic diseases, including their
frequency and severity [53, 54].
 The symptoms of rhinoconjunctivitis reported in
urban centers of developing countries are more severe
than those reported in developed countries [55].
 IgE sensitization to aeroallergens occurs early in life
and at higher frequencies compared to temperate
areas [13, 56, 45].
 The main sensitizers in allergic patients living in
tropical urban environments are HDM [57] and
cockroach [58–60]. IgE response in airway allergy
is dominated by a single class of allergen source,
dust mites.
 There are no significant differences in the allergen
levels during the year [61].
 The frequency of IgE sensitization and the strength
of IgE levels to cross-reactive pan-allergens like
tropomyosin are higher compared to temperate
areas [62].
 Sensitization to pollens is less frequent and less
intense than to mite allergens. In regions with
transition to subtropical areas the role of pollens is
important, although the pattern of sensitization is
different to that observed in Europe [63, 64].
 IgE sensitization to food allergens is frequently
detected without symptoms and aeroallergen
sensitization is not usually preceded by food
sensitization. The sources of food allergens are
different; for instance hypersensitivity to shellfish,
fish and fruits is more common than reactions to
nuts, peanut and wheat [65–67].
Early respiratory symptoms and allergen sensitization in the
Tropics
It is well recognized that wheezing is frequent in the
Tropics and several factors have been implicated including
viral infections, elevated endotoxin levels and pollutants
[46, 68, 69]. However, there are few studies on the atopic
component of early wheezing in the Tropics, which has
made the analysis of this important point based on reports
from temperate countries. A birth cohort conducted in
Salvador-Bahía (Brazil) with full evaluation by physicians
and skin prick tests reported that 25 % of children by age
5 years have allergic respiratory symptoms [70]. In addition,
in a nested case-control study in children from Esmeraldas
(Ecuador) it was found that 32.69 % of wheezers and 10.8 %
of controls living in urban zones were HDM sensitized as
detected by serum specific IgE, a highly significant differ-
ence [71]. Furthermore, the evaluation of early sensitization
in the FRAAT cohort (Cartagena, Colombia) revealed that
33.3 % of 3 years old children were sensitized to B. tro-
picalis, and this was a risk factor for wheezing [13]. IgE
sensitization to Ascaris has also been associated with
wheezing in children sensitized to mites or food allergens
[71, 72]. The influence of allergen sensitization on wheez-
ing has been detected, although at a low rate, even in
parasited communities and using skin testing for atopy
diagnosis [73]. All of these finding suggest the great im-
portance of early sensitization to mite and Ascaris aller-
gens, although a proportion of wheezing is driven by non-
IgE pathways, more likely viral infections. However, as will
be discussed later (see Allergen sensitization and asthma
symptoms) sensitization rates increase with age and in
older children reach impressive levels. In addition, mater-
nal antecedent of allergic disease is an independent risk
factor for wheezing and asthma in the offspring [74]. It
has been also found that maternal effects are significant
for boys but not for girls [75].
In summary, there are few studies addressed to establish
the natural history of allergic disorders in the Tropics.
Although not well investigated, childhood viral infec-
tions seem to be as prevalent as in temperate zones,
being an important cause of wheezing, the commonest
respiratory symptom in infancy. In addition, there are
reports suggesting that it is associated with IgE
sensitization to mite and helminth allergens. One
striking finding has been the low prevalence of doctor
diagnosed AD in several populations and the absence
of the “atopic march” described in some temperate
countries. The progress and severity of asthma is in-
fluenced by helminth infections. It is more frequent in
urban areas where helminths are less prevalent and
with lower parasitic load.
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The prevalence and particularities of allergic diseases in
the Tropics
Because of the increasing trends of allergy in industrial-
ized countries, one frequently discussed issue regarding
allergy in the Tropics is its prevalence. Although in the
past it was difficult to understand, now it is generally ac-
cepted that allergic disorders are very common in under-
developed countries of the Tropics. In addition to lack
of information, there were several reasons for this belief.
The first was the “tropical diseases” idea: in this zone
the diseases were limited mainly to infections. This was
reinforced by the influence of the hygiene hypothesis, so
well accepted that for many minds it ceased to be a hy-
pothesis and made it difficult to reconcile the existence
of allergic problems with the high prevalence of bacterial
and viral infections in the same regions. Another reason
was the increasing number of basic science reports
showing the important immunomodulatory effects of
helminth infections, which has been wrongly generalized
to conclude that allergies are rare in places where hel-
minthiases exist.
Interestingly, during the last years several well con-
ducted epidemiological surveys have demonstrated the
high prevalence of allergic diseases in tropical under-
developed countries. In addition, the hygiene hypothesis
has failed to resolve important contradictions with em-
pirical data and finally, the immunostimulatory effects of
helminthiases have been evaluated at the population
level. Based on the limited historic information available,
it is very difficult to define if there is an allergy epidemic
in the Tropics or how long these diseases were present.
However, since tropical centers started to be involved in
the Study of Asthma and Allergies in Childhood (ISAAC),
it was evident that asthma and rhinitis were very frequent
in some cities. We do not know if this trend came from
long or even if the natural exposure to mite allergy in-
duced underdiagnosed allergy symptoms. In the follow-
ing five sections we will review the prevalence and
relevant clinical aspects of some allergic conditions.
Asthma and rhinitis as well as atopic dermatitis will be
analyzed by including both ISAAC and regional studies
from the Tropics.
Asthma and rhinitis in children
Asthma and rhinitis are among the most common
chronic illnesses of childhood, with significant impaired
quality of life [76–80]. Studies worldwide have shown an
increasing trend in their prevalence over the last de-
cades. ISAAC Phase I (conducted in the early 1990s’)
and Phase III (2001–2003) detected an overall increase
in the prevalence of rhinoconjunctivitis which was more
marked in older children [81]. There was an increase in
asthma prevalence as well, especially in regions where it
was lower [82]. However, there are regional surveys,
some relatively recent, that may be able to shed more
light on other local factors pertaining to allergic diseases.
In fact, interesting information resulted when analyzing
the pattern of asthma [83] and rhinoconjunctivitis [81]
within the tropical ISAAC centers; comparing these
patterns with the subtropical and temperate ISAAC
centers and reviewing the regional surveys in the Tropics
pertaining to the patterns of asthma and rhinoconjuncti-
vitis (Table 1, Additional file 1: Table S1 and Additional
file 2: Table S2).
Comparison of tropical, subtropical and temperate ISAAC
centers
Prevalence of current rhinitis and current rhinoconjunc-
tivitis between Phase I and Phase III increased in the
Tropics and subtropics, and was higher in subtropical
centers compared to tropical centers, for all children as
well as children aged 13–14 years, but not in children
aged 6–7 years. In contrast, the diagnosis of asthma ever
was lower in the subtropics compared to the Tropics
(Table 2). Comparing the Tropics and temperate centers,
the symptoms of current rhinitis, current rhinoconjunc-
tivitis, and a diagnosis of hay fever ever were higher in
the Tropics, especially in children aged 6–7 years. Symp-
toms of current rhinoconjunctivitis and change in preva-
lence of hay fever ever were significantly higher in the
Tropics compared to the temperate centers, in children
aged 13–14 years. When comparing subtropical with
temperate centers, similar results were obtained.
Regional, non-ISAAC studies on asthma and rhinitis
A total of 13 surveys [28, 84–97], all cross-sectional and
describing asthma or rhinitis in children in their re-
spective communities within tropical countries was
found (Additional file 2: Table S2). Twelve reported the
prevalence of asthma and/or wheeze in the last 12 months
and two presented the prevalence of rhinoconjunctivitis.
With one exception [84] all recruited at least a thousand
or more children. Four studies looked at children in rural
communities [84, 87, 90, 95]; the rest were in urban envi-
ronments. Most of these surveys employed ISAAC ques-
tionnaires and definitions in their methodology. Three
used different criteria to define asthma. Response rates
were excellent in all except one study, where only 48 % of
subjects returned the questionnaires [92].
As in ISAAC surveys, the rates of current wheeze and/
or asthma varied widely, ranging from 3 % in Tumbes [87]
to around 27 % in Costa Rica [28]. In the four rural stud-
ies, asthma prevalence was generally low, ranging from 3
to 10.5 %, with the exception of the study involving the
Warao Amerindians (26 %) in Venezuela [84]. Prevalence
of asthma, symptoms of rhinitis and rhinoconjunctivitis
varied widely. In two large studies in Mexico [85, 86],
asthma was most prevalent in Villahermosa (10.2 %),
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rhinitis and rhinoconjunctivitis were highest in the South-
east Federal District of Mexico (53 % rhinitis, 25.7 % rhi-
noconjunctivitis) and lowest in Toluca (asthma 5.9 %,
rhinitis 18.6 %, rhinoconjunctivitis 7.3 %).
The ISAAC studies encompassed children all over the
world, and Mallol et al. [98] detected a weak but signifi-
cant inverse relationship between latitude and prevalence
of asthma and rhinoconjunctivitis. The available data from
the Tropics suggest that for current rhinoconjunctivitis,
current wheeze, hay fever-ever and asthma-ever, the effect
of latitude is important, especially in children aged 13–14
years. This implies that the closer to the Equator, the
higher the prevalence of symptoms in children as they get
older. These findings could be associated to particular
conditions observed in the Tropics.
One is the effect of ultraviolet-B radiation, which is linked
to Vitamin D and is assumed to be associated with latitude
but remains a controversial issue. The Tasmanian Longitu-
dinal Health Study [99] found that proximity to the equator
and higher ultraviolet-B exposure was associated with
higher rates of atopy and atopic sensitization. In contrast
other authors [100] did not find association between
Vitamin D, ultraviolet radiation and asthma. Further-
more, a lower serum level of 25-hydroxy vitamin D has
been associated with higher risk of asthma and more
severe asthma in both the Tropics [101, 102] and other
countries [103], which contradict the assumptions of
the relationship between latitude and vitamin D status.
Finally, latitude might have an indirect effect on the de-
velopment of atopic symptoms through alteration of
the magnitude [104] of protective or risk factors for dis-
ease; therefore, further research in this area is mandatory.
Another, more documented factor is the effect of
house dust mites, which are the major aeroallergens in
the Tropics in terms of prevalence and contribution to
atopic disease, as has been demonstrated in multiple
studies [60, 105–115]. House dust mite sensitization also
appears to increase with age [105], again suggesting a
time-dependent risk of sensitization. Though the dual
allergen hypothesis [116] was initially formulated to ex-
plain peanut allergy, it might also hold true for dust mite
allergy: children (and adults) in the Tropics would have
considerable cutaneous (as well as possible inhalation)
exposure to dust mite allergens when they sleep. This
risk of sensitization would be exposure-dependent and
therefore increases with age, which would explain the
observations of Chiang et al. [105] as well as the effect
we found in older children in the Tropics.
The differences between temperate regions and the
tropic/subtropics are quite marked. It is also noteworthy
that between Phase I and Phase III, the increase in preva-
lence of current rhinitis and rhinoconjunctivitis was highest
in the subtropics compared to either Tropics or temperate
regions. Such differences highlight two key points. One is
the possibility that other factors beyond sensitization to
dust mites account for the rapid rise in atopic symptoms in
the subtropics, which merits further study on the pathogen-
esis for atopic disease and its relationship with the environ-
ment in this region alone. Given that environmental factors
influence the success of any intervention intended to
change the trends of atopic disease, current data from the
general scientific literature (almost all from temperate
climates) may not be applicable to children in the Tropics.
Further study in this part of the world is needed especially
in the areas of environmental influences and environmental
interventions.
In summary, asthma and rhinitis prevalence in children
living in the Tropics is higher than that reported in
temperate countries for the same age groups. An overall
increase of allergies from ISAAC I to III was observed,
similar to that in temperate countries. In addition a trend
for increasing allergy symptoms in places closer to the
Equator was observed, suggesting an effect of latitude
that deserves more study.
Atopic dermatitis
AD is widely distributed, particularly among children under
5 years. There is growing information about increase of AD
Table 1 Overview of children studied in tropical centers in ISAAC Phase III













Current rhinitis 86 32.6 12.5 49 24.1 11.2
Change per year in Current Rhinitis 26 +0.26 1.15 17 +0.26 0.84
Hay Fever ever 80 20.8 14.6 46 15.7 10.1
Change per year in Hay Fever ever 22 +0.95 1.72 15 +0.73 1.46
Current rhinoconjunctivitis 86 15.2 6.9 48 9.5 5.3
Change per year in Current
rhinoconjunctivitis
26 +0.06 0.99 17 +0.19 0.29
Current wheeze 86 13.0 6.8 49 12.8 8.5
Asthma ever 86 13.0 7.1 49 10.9 8.4
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Current rhinitis: Whole Cohort 29.5 (12.7) 28.5 (11.8) 25.0 (9.1) 0.001 1.03 NS 4.47 0.001 3.44 0.028
Current rhinitis: Age 13–14 years 32.6 (12.5) 32.5 (12.1) 29.4 (8.5) NS 0.01 NS 3.12 NS 3.11 NS
Current rhinitis: Age 6–7 years 24.1 (11.2) 21.8 (7.9) 18.5 (5.4) 0.002 2.31 NS 5.58 <0.001 3.28 NS
Change per year in Current rhinitis:
Whole Cohort
0.26 (1.03) 0.93 (1.30) 0.32 (0.93) 0.02 −0.67 0.01 −0.06 NS 0.61 0.009
Change per year in Current rhinitis:
Age 13–14 years
0.26 (1.15) 1.07 (1.46) 0.29 (1.11) 0.046 −0.81 0.03 −0.04 NS 0.78 0.018
Change per year in Current rhinitis:
Age 6–7 years
0.26 (0.84) 0.59 (0.77) 0.36 (0.56) NS −0.33 NS −0.10 NS 0.23 NS
Hay Fever Ever: Whole Cohort 18.9 (13.3) 21.2 (15.2) 14.6 (10.7) <0.001 −2.14 NS 4.37 0.004 6.51 <0.001
Hay Fever Ever: Age 13–14 years 20.8 (14.6) 24.2 (14.5) 18.4 (11.7) NS −3.39 NS 2.44 NS 5.83 0.017
Hay Fever Ever: Age 6–7 years 15.7 (10.1) 16.0 (15.2) 9.0 (5.5) <0.001 −0.31 NS 6.70 <0.001 7.01 0.002
Change per year in Hay Fever Ever:
Whole Cohort
0.86 (1.60) 0.69 (1.05) 0.37 (0.61) 0.025 0.18 NS 0.49 0.01 0.31 NS
Change per year in Hay Fever Ever:
Age 13–14 years
0.95 (1.72) 0.76 (1.17) 0.38 (0.70) NS −0.19 NS 0.58 0.033 −0.38 NS
Change per year in Hay Fever Ever:
Age 6–7 years
0.73 (1.46) 0.47 (0.62) 0.36 (0.47) NS 0.25 NS 0.37 NS 0.11 NS
Current rhinoconjunctivitis:
Whole Cohort
13.1 (6.9) 13.3 (7.4) 10.7 (5.3) 0.001 −0.13 NS 2.43 0.001 0.26 0.005
Current rhinoconjunctivitis:
Age 13–14 years
15.2 (6.9) 16.1 (7.3) 13.2 (5.0) 0.015 −0.95 NS 2.00 0.031 2.95 0.01
Current rhinoconjunctivitis:
Age 6–7 years
9.5 (5.3) 8.6 (5.0) 7.0 (3.0) 0.011 0.87 NS 2.42 0.003 1.55 NS
Change per year in Current
rhinoconjunctivitis: Whole Cohort
0.11 (0.79) 0.59 (0.77) 0.12 (0.57) 0.006 −0.48 0.005 −0.01 NS 0.47 0.002
Change per year in Current
rhinoconjunctivitis: Age 13–14 years
0.06 (0.99) 0.66 (0.86) 0.09 (0.71) 0.027 −0.61 0.018 −0.03 NS 0.58 0.011
Change per year in Current
rhinoconjunctivitis: Age 6–7 years
0.19 (0.29) 0.41 (0.52) 0.17 (0.26) NS −0.22 NS 0.02 NS 0.24 NS
Current wheeze: Whole cohort 12.9 (7.5) 11.6 (6.5) 12.7 (6.5) NS 1.32 NS 0.85 NS −0.48 NS
Current wheeze: Age 13–14 years 13.0 (6.8) 11.5 (5.9) 12.9 (7.2) NS 1.53 NS 0.05 NS −1.48 NS
Current wheeze: Age 6–7 years 12.8 (8.5) 11.9 (7.6) 10.8 (4.9) NS 0.97 NS 2.02 NS 1.05 NS
Asthma Ever: Whole Cohort 12.2 (7.7) 8.9 (5.0) 11.2 (8.3) 0.009 3.36 0.002 1.04 NS −2.32 0.028
Asthma Ever: Age 13–14 years 13.0 (7.1) 9.8 (5.1) 12.3 (8.6) NS 3.23 0.019 0.70 NS −2.53 NS















prevalence, nevertheless high variation in the frequencies is
observed [117]. The most known international effort evalu-
ating the epidemiology of AD is the ISAAC study, using a
questionnaire completed by the participants based in the
Williams diagnostic criteria [118]. Several centers from
tropical countries participated in ISAAC phase I and III,
and for some the prevalence of AD was found higher than
in other regions, with a mode of 15 %. This suggests that
genetic and environmental factors have an important effect
in the development of AD. Since the surveys were com-
pleted by the participants other explanations like selection
bias and misidentification of the disease by the patient
should be considered. In this section we compare the
prevalence of AD in tropical countries as reported by the
ISAAC and surveys using other commonly diagnostic tools.
In addition, we evaluate the impact of infectious skin prob-
lems on the differential diagnosis of AD.
Challenges for the diagnosis of AD in the Tropics
For diagnosis, the presence of pruritus and at least two
of the other criteria is essential. However, these symp-
toms are not pathognomonic of AD and could be
present in other skin diseases. In tropical countries,
especially in underdeveloped areas, other causes of
pruritus and lichenified injuries are common (scabies,
papular urticaria, seborrheic dermatitis, miliaria, infection-
induced rashes, etc.). Miliaria, also called “sweat rash” or
“heat rash”, is a skin disease marked by small and itchy
rashes [119], common in hot and humid conditions, such
as in the Tropics and during the summer in subtropical
regions. Although it affects people of all ages, it is espe-
cially common in children and infants. Papular urticaria
is caused by hypersensitivity reaction to insect bites.
Scabies is a common skin disease especially in children
under 10 years (9 %) caused by infection with the mite
Sarcoptes scabiei [120, 121]. The characteristic symp-
toms of a scabies infection include intense itching and
superficial burrows.
In South India, Brazil and Turkey, more than 30 %
of children under 7 years had miliaria and the main
differential diagnosis was AD [122–124]. These studies
showed that the etiologies of around 50 % of derma-
toses were infections such as scabiosis; nevertheless
between 50 and 80 % of cases were initially diagnosed
as AD, which was the second most frequent skin prob-
lem with prevalence between 6.5 and 12 %. It is also
common that some of these diseases appear simultan-
eously, hindering the diagnosis and appropriate treat-
ment. In Nigeria one study including 1.066 children
under 12 years observed that about 20 % of children
with dermatoses have two or more skin disease [125].
AD was virtually absent (<1 %) but 60 % of patients
had another skin disorder with scabiosis being among
the most common.
ISAAC results on AD
There were seven questions of the ISAAC survey fo-
cused on AD; in addition two combinations of symp-
toms were evaluated: current symptoms and current
symptoms of severe AD. Five of the seven questions
were focused on pruritus, and positive response could
suggest that the child has or had dermatitis. However
excepting the question about lesions distribution none
could differentiate if the itching was secondary to other
common skin conditions, especially those described
above. According to ISAAC Phase I and Phase III re-
sults, the prevalence of “eczema ever” in tropical coun-
tries among children aged 6–7 years, varied from 5 % in
Jodhpur (India) to 44 % in Quito (Ecuador). The presence
of “current eczema” varied from 0.9 % in Jodhpur to 22.5 %
in Quito. In children between 13 and 14 years, the preva-
lence ranged from 0.2 % in Tibet (China) to 24.6 % in Bar-
ranquilla (Colombia). All centers in tropical areas from
Latin America and Asia showed a significantly higher risk
of current symptoms. La Habana (Cuba) and San Pedro
Sula (Honduras) were the centers with the highest risk of
current symptoms of severe eczema in tropical regions
(two out of three patients). In summary, the ISAAC studies
provide information about the prevalence of AD in the gen-
eral population in several countries to compare the results
and identify possible risk factors. However, the age of the
patients who underwent the questionnaire and the type
of questions answered by self-reporting may lead recall
bias especially in tropical regions, where many other
itchy skin diseases are highly prevalent.
Comparison of ISAAC and other epidemiological studies in
tropical countries
In tropical areas, one of the most highlighted results of
ISAAC Phase III was the increasing prevalence of AD
compared with Phase I, especially in Latin American
countries. A higher frequency of current dermatitis among
children 6 to 7 years (24 %) was observed in Barranquilla-
Colombia. These results contrast with data from a similar
study done in this city by Dennis et al., the same year with
the same ISAAC questionnaire and similar size population
where a parent-reported prevalence of current eczema
was less than 7 % [7]. In that study, the prevalence of
medical diagnosed AD was less than 2 %. The frequency
of severe eczema was similar between studies. Ten years
later, in a second study Dennis et al. using the same meth-
odology found that the prevalence of parent-reported AD
in Barranquilla was 11 % and medical diagnosis less than
7 % [126].
In Cartagena, data from the FRAAT birth cohort
showed that none of the children at age of 3 years had
developed AD [46]. Given that the ISAAC study carried
out the survey among families with children over 6 years
and FRAAT results were in a population with less than
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3 years, these results suggest that in some cities in Latin
America the onset of dermatitis is later in life (>3 years)
similar to that found in some tropical countries located
in the South-East of Europe [127]. However, the follow-
up study FRAAT at 5 years has shown no change in the
prevalence of dermatitis. Another possible explanation
may be the methodology of data collection; in the
FRAAT cohort, ISAAC questionnaire was applied to-
gether with a physician examination.
In a study from Cuba, Gruchalla et al. showed marked
differences between results of ISAAC questionnaire or
physician diagnosis of dermatitis [128]. A total of 398
children from five randomly selected primary schools
were included in the study; age range was 5–13 years
(median 8 years). Parents or guardians were interviewed
by using an extended version of the ISAAC question-
naire. Additionally, a physician made a physical examin-
ation of each child. A thorough inspection of the skin
for signs of AD was done. For AD, the answers to the
seven core questions yielded symptom percentages
between 8 and 26 %. Using the ISAAC definition for AD
[118] 9 % of the children were considered as suffering
from AD, and 3.5 % as severe AD. When physician
evaluation was done, only five children (<2 %) showed
clinical signs of AD, which means a significant difference
in prevalence as reported by ISAAC questionnaires. In
addition, by applying the score of Yamada et al. [129]
19 % had AD. These data show a significant variation in
prevalence according to the questionnaire used to define
AD and in both systems dermatitis prevalence was over-
estimated as compared to the clinical examination.
In summary, although there are several population
studies on AD, very little is known about the actual
prevalence, especially outside Europe. The ISAAC per-
mits comparisons to estimate the global burden of AD,
to generate new hypotheses on disease causation that
may only become apparent when prevalence data on a
global scale are examined, and to test existing hypoth-
eses regarding disease etiology on a wider scale. Never-
theless, ISAAC has limitations and the results have to be
taken with precaution especially in tropical regions
where other skin itchy disorders are frequent. Studies
that include objective skin examinations are required to
confirm the prevalence in these regions.
Urticaria
Urticaria is a highly prevalent condition with various
clinical manifestations [130–132]. When the symptoms
are present for less than six weeks it is considered acute
urticaria (AU), otherwise it is termed chronic urticaria
(CU) [131, 133]. Although accurate data on the preva-
lence of urticaria is unavailable, it ranges from 0.03 to
11.3 % [130, 134]. It may affect between 15 and 30 % of
individuals at some point of their life [133, 135–138].
Around 25 % of AU can evolve to CU forms [138]. CU re-
solves spontaneously in 30–55 % of patients within 5 years
[139]. Autoimmune disturbances are present in 40 to 45 %
of patients with CU. Recently urticaria management guide-
lines have been published in both temperate and tropical
countries, wherein definition, classification, risk factors
and treatment are extensively described [130, 138, 140].
Sánchez-Borges et al. investigated the demographic
and clinical characteristics of urticaria patients attending
allergy clinics in Caracas, Venezuela during a three-year
period; patients with urticaria were 21.8 % of all consulting
to the allergy services, 40.1 % AU and 59.8 % CU. AU was
more frequent in adult female subjects; 31 % presented
generalized urticaria. Papular urticaria occurred more
frequently in children (39.4 %) than in adults (9.9 %),
whereas drug-induced urticaria were observed mainly in
adults [136]. In Mexico City, Cariño et al. performed a
retrospective, analytical, descriptive study of patients
treated at the Department of Allergy and Clinical Immun-
ology. They included 1913 patients, of whom 186 (9.7 %)
were diagnosed as urticaria, angioedema or both, 47 were
men (25.2 %) and 139 women (74.7 %). The highest preva-
lence was found in adults (90.3 %), the mean age was
37.4 years [141]. The results of these studies are similar to
those reported in temperate countries.
There is scarce information about the characteristics of
urticaria in tropical countries, where infections and espe-
cially parasitic infections are widespread and their immuno-
pathology is of great importance [142]. There is evidence
that parasitic infections may sensitize the host and the asso-
ciation of AU or CU with infection by Giardia lamblia,
Fasciola hepatica, Toxocara canis, Echinococcus granulosus,
Strongyloides stercoralis, Hymenolepis nana, Blastocystis
hominis, Ascaris lumbricoides and Anisakis simplex has
been reported, suggesting that parasitic infections should
be considered as an important cause of chronic urticaria
[143, 144]. Nenoff et al. observed that treatment with
metronidazole or tinidazole successfully improved pruritus
in three patients who had chronic urticaria or pruritus and
asymptomatic intestinal infection with Giardia lamblia
[145]. Other investigators, believing that this parasite is an
important urticaria-inducer, conducted a clinical trial of
immunotherapy with Giardia extract in patients with CU
sensitized to Giardia [146]. Additionally, it was observed
that patients with urticaria were significantly more likely
to have ≥ 5 Blastocystis hominis organisms per field on
microscopic examination of feces [147]. In a study car-
ried out in Egypt, Fakkar et al. investigated the associ-
ation of B. hominis with urticaria. In total, 54 patients
with urticaria and 50 controls were enrolled; the para-
site was detected in a significantly higher number of
patients as compared to the control group. The amoeboid
form was found in 60.6 % of Blastocystis-positive patients
with urticaria, but in none of the healthy controls [148].
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In summary, urticaria is a common problem in the Tro-
pics and seems to be clinically similar to that in temperate
zones. Risk and triggering factors are probably different in
the Tropics but as the information is so scarce, it is not pos-
sible to conclude. Prospective studies and well-structured
research are obviously needed, particularly to define the
role of parasites as risk factors [149].
Papular urticaria
Allergic reaction to stinging insects can be immediate
(IgE-mediated) or delayed (24–48 h) with predominance
of cellular components. Among clinical conditions related
to insect bite hypersensitivity, Papular Urticaria (PU) is a
common manifestation in the Tropics. PU is an allergic
and chronic skin disease caused by insect bites, with fleas
and mosquitoes being the most common causal agents.
PU usually appears during the first year of life; normally it
improves by the age of seven years, but there are excep-
tions that persist until adulthood [150]. This is one of the
most particular allergic tropical problems although it can
be observed in any place where causal insects are present.
Clinical manifestations
The disease is characterized by a delayed hypersensitivity
reaction such as papule-type skin lesions, which is the
most common, or wheals, vesicles, blisters and scabs.
Patients might develop hypo or hyper chromic residual
pigmentations in the skin; moreover, it produces intense
pruritus, severe secondary infections and scarring [150].
Hudson et al. carried out a study on a group of subjects
with clinical background of papular urticaria, who were
bitten on the forearms by fleas of different species (C. felis,
P. irritans and P. simulans) and observed for 15 days.
Twenty minutes after bite a wheal appeared (with or with-
out erythema) and was classified as an immediate hyper-
sensitivity reaction. After 24 h, the reaction changed to
papules or vesicles and was considered a delayed response.
In some cases, a bullous eruption developed after 24–48 h
[151]. Similar results were obtained from Japan with mos-
quito bites: 65 % of patients presented delayed response
(with or without immediate response); 29 % presented
immediate reaction only and the remaining 6 % did not
react [152]. Mosquitoes produce lesions in different areas
such as the face, limbs and exposed areas of the trunk. On
the other hand, lesions produced by fleas are more com-
monly located in pressure areas such as the waist, under
the socks and in the extremities (Fig. 1).
Causal insects
More than 3000 species of mosquitoes are distributed
worldwide [153]. Some of these are clinically relevant
including Aedes aegypti, Aedes vexans and Culex quin-
quefasciatus [154–156]. Adult female mosquitoes require
blood-feeding to produce eggs. In this process, they bite
and inject their saliva before sucking their victim’s blood
[157]. Mosquito saliva contains various substances like
lysozymes, antibacterial glucosidases, anticoagulants, an-
tiplatelet aggregating factors and vasodilators [158–162].
Fleas are obligate blood sucking ectoparasites. This group
is composed of 2.574 species belonging to sixteen families
(Fig. 2), but only a small number are closely associated
with humans [163]. Most fleas of medical importance, such
as Pulex irritans (known as the human flea) and the cat
flea, Ctenocephalides felis, belong to the Pulicidae family
[164, 165]. Other species related to humans are Ctenoce-
phalides canis, usually known as the dog flea but can at-
tack other animals and humans; and Tunga penetrans,
usually found in the sand. Species more often involved in
human infections are Ctenocephalides felis, Ctenocepha-
lides canis and Pulex irritans [166]. Fleas have great
capacity to adapt to different home environments. The life-
cycle is temperature dependent and ranges from 14 days at
32 °C to 130 days 13 °C [167]. In temperate countries,
mosquito season starts slowly in the spring, when warm
Fig. 1 Skin lesions in papular urticaria. a Crops of erythematous
papules induced by flea bites in a patient living in Bogotá, Colombia.
b Hyperchromatic residual pigmentations in legs after resolution
of mosquito bite-induced papules in a patient from Cartagena,
Colombia. Covered body areas (i.e. trunk and back) are more prone
to flea bites. Mosquito bites predominate in exposed areas, such as
legs, arms and neck
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weather brings out the first of the bugs, peaks in summer
and tapers off into fall [168]. In the Tropics, optimal condi-
tions for mosquito survival are perennial. In India varia-
tions in the frequency of PU according to the season were
found, being most frequent (16.7 %) in rainy season [169].
Burton et al. [170] reported that fleas are more common in
temperate countries and mosquitoes in tropical countries.
Prevalence
There are several studies about the frequency and preva-
lence of PU in the Tropics. In Mexico City, a frequency
of 16.3 % was found [171]; which decreased to 2.24 %
twenty years later [172], probably because of improvement
in sanitation, housing, and socioeconomic conditions. In
Venezuela, Mendez et al. [173]; after dermatological evalu-
ation of 177 Venezuelan children from a rural area, showed
that PU was the commonest skin disease (25.4 %). Sanchez-
Borges et al. [174] reported that PU was present in 39 % of
children and 9.9 % of adults with acute urticaria attending
an allergy outpatient clinic in Caracas, Venezuela. In Brazil
9 % of 19.410 cases attending an outpatient clinic in
Curitiba were diagnosed as PU [175]. In Colombia,
Chaparro et al. developed the first population-based study
to determine the prevalence of the disease in Bogota
Colombia, they noted that the prevalence of PU caused by
flea bite was 20.3 % (95 % CI: 18.2 to 22.5 %) [176].
In Africa PU is regularly seen among schoolchildren,
especially in countries with hot and humid climate. Stud-
ies carried out at the Dermatology Center of Bamako in
Mali, reported that 6.8 % of 3479 children had PU [177]. In
Nigeria, a prevalence study of skin disorders was conducted
in a public primary school, including 529 (49.6 %) boys and
537 (50.4 %) girls with a mean age of 8.8 ± 2.5 years, PU
was diagnosed in 35 children (3.3 %) and fungal infections
and scabies were the most common skin diseases, whereas
allergic conditions were nearly absent [125]. In a cross-
sectional, population-based survey done in Ghana, Gabon,
and Rwanda [178], the prevalence of skin diseases was
estimated on the basis of physical examination by at least
one dermatologist; 4.839 schoolchildren were seen and the
PU prevalence was 1–2 %. In Brazzaville, Congo, a region
located near a watercourse, PU prevalence studies were
conducted at 100 and 500 m from the river [179], reporting
a higher frequency near water and in children 6 to 8 years
old. In India, a 5.2 % prevalence of PU in 2100 children was
found, attributed to the tropical weather conditions in this
coastal area [180]. In Pakistan, a case-series reported in
2007 where individuals of all age groups and gender having
definite history of insect bites were included in the study.
Out of 14.019 subjects who visited the Dermatology Out-
patient Department of the Combined Military Hospital,
Abbottabad, during the study period, 280 (2 %) patients
were diagnosed as having PU [181].
Immunopathogenesis
Most of the information about immunological mecha-
nisms associated to PU comes from the flea bite disease;
histopathology suggests the involvement of an allergic
Fig. 2 Phylogenetic tree of fleas and mosquitoes. In red the most frequent species that bite humans. Fleas group includes 2.574 species. More than 30
genera and 20.000 species of mosquitoes are distributed worldwide
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component since an inflammatory infiltrate of eosinophils
and lymphocytes is common, a pattern also found in biop-
sies from Colombian patients [182]. Interestingly, 80 % of
patients had negative skin prick test to flea extract, prob-
ably because a somatic extract was employed and most al-
lergens involved in this type of hypersensitivity are found
in the insect’s saliva [183]. It should also be mentioned
that in patients with reactions to mosquito bites as well
only 17.6 % had positive skin test to this source [184]. A
Th2 polarization of cellular immune response was ob-
served in patients with PU induced by flea bite, given that
after a polyclonal stimulation of peripheral mononuclear
cells, a greater percentage of CD4+ IL-4+ T lymphocytes
was detected when compared to healthy subjects, while
the proportion of positive IFN –gamma T lymphocytes
was significantly reduced [185].
Some flea extract components, such as 31–35 kDa, are
more frequently recognized by serum specific IgE from
PU children. Furthermore, components between 16 and
20 kDa were only recognized by patient sera [186]. In
addition, higher basophil activation was found in children
with PU when tested with fractions of different molecular
weights from the flea body extract [187]. Different studies
have been done to assess the role of IgE in mosquito-
induced PU. Reunala and coworkers did not find signifi-
cant differences in the IgE-binding frequency between
PU patients and control subjects coming from tropical
areas (Kenya and Mexico); which contrasts with the re-
sults observed in Finish patients displaying hypersensitiv-
ity reactions to mosquito bites, where a statistical
difference in the response between patients and controls
was very clear [188–190]. Another study performed in
Egypt showed significant differences in the IgE recogni-
tion of bands from extracts of Pulex irritans and Culex
pipiens [191].
Regarding IgG responses, frequency of band recogni-
tion by the IgG3 isotype was significantly greater in the
control group. In addition, the humoral response profile
changes in a time dependent manner. Patients having
more than 5 years from the beginning of the symptoms
show IgG3 reactivity rates which are similar to the
control group, especially for proteins between 31 and
35 kDa [186]. There is an increasing interest in evaluat-
ing purified, mainly recombinant antigens and allergens
involved in PU. There are several mosquito recombinant
allergens causing immediate IgE hypersensitivity reac-
tions in humans [192–194], as well as molecules of cat
flea associated with allergic dermatitis in dogs [195], but
there are no reports about their involvement in PU.
In summary, PU is an important allergic problem in
the Tropics and causes great morbidity, especially in
children. The immunopathogenesis of this condition in-
volves mainly a cellular inflammatory infiltrate that
seems to be guided by a Th2 response. The role of IgE
in the pathogenesis is not clear. Allergens from mosqui-
toes and fleas are not completely characterized.
Anaphylaxis
Recent guidelines on anaphylaxis have proposed that the
elements that facilitate the initiation of these severe re-
actions are similar worldwide [196]. In this section we
will present a brief description of the most common risk
and aggravating factors for anaphylaxis and will discuss
some characteristic aspects observed in tropical and de-
veloping countries. We will consider age, physiologic
state; presence of concomitant diseases; concurrent use
of medications and other cofactors that amplify anaphyl-
actic reactions, as well as certain clinical expressions pe-
culiar to the Tropics (Table 3).
Age
There are specific characteristics of anaphylaxis that dif-
fer according to patient’s age. For example, in infants
some foods such as cow’s milk, eggs, peanuts, nuts, fish/
seafood, fruits, and soy are frequently involved [197]. In
the Latin American Survey on anaphylaxis 31 % of pa-
tients were younger than 6 years; and foods (36.1 %),
drugs (27.7 %), and insect stings (26.2 %) were the most
common offenders [198]. The presence of asthma deter-
mines a higher severity of the episodes [199]. In adoles-
cents, the risk taking behavior increases exposure to
Table 3 Risk factors for anaphylaxis in tropical settings
Factor
Age • Children: foods, drugs, insects, asthma
• Adolescents: risk behavior (alcohol,
drugs)
• Adulthood: drugs, foods, insect venoms
Physiological status • Perimenstrual
• Pregnancy: drugs, latex








• Calcium channel blockers
• Angiotensin receptor blockers
• Diuretics






• Disruption of routine
• Pollinosis
• Increased tryptase concentrations
• Poor hygienic conditions
• Weak health systems
• Low educational level of the population
• Poor adherence to management
guidelines
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etiologic agents related to anaphylaxis [196], while in
aged people drugs, foods, and insect venoms are often
involved [200–202]. Women are particularly prone to
suffer anaphylaxis during the perimenstrual period. Also
pregnant women are especially susceptible during deliv-
ery due to allergic reactions to drugs (penicillin) or latex.
Concomitant diseases
Severe or uncontrolled asthma and other chronic re-
spiratory diseases [203], cardiovascular diseases [204],
and mastocytosis [205, 206] are commonly observed in
patients who develop anaphylaxis. In Latin America
asthma is present in 41.9 % of children with anaphylaxis
[198]. However, regarding drug-induced anaphylaxis
(DIA) a recent study carried out in Latin America did
not identify any specific host risk factors [207]. In fact,
asthmatic and atopic patients presented less severe DIA
reactions, an observation that contradicts other studies
where asthma and AD were associated with a signifi-
cantly greater risk of anaphylaxis [208].
In Brazil, Aun et al. observed a high frequency of
atopy and asthma in patients with DIA, although those
conditions were not associated with the severity of the
reaction. Also, a previous hypersensitivity drug reaction
with the same drug was present in 15 % of patients with
DIA [209]. In children with anaphylaxis repeated attacks
occurred in 42.0 % [198]. These observations emphasize
the need for adequate patient’s and physician’s education
in order to prevent undesirable recurrences.
Concurrent medications
The intake of beta blockers, angiotensin converting en-
zyme inhibitors, calcium channel blockers, angiotensin
receptor blockers and diuretics can increase the risk of
anaphylaxis, and this association is especially frequent in
old people [202]. In addition, nonsteroidal anti-
inflammatory drugs (NSAIDs) have been shown to en-
hance anaphylaxis [210]. This observation has to be
taken into account especially in developing countries
where NSAIDs are easily obtained without a medical
prescription.
Other cofactors that amplify anaphylaxis
A number of other elements have been incriminated as
exacerbating factors of anaphylaxis [210]. They include
exercise, emotional stress, acute infections, fever, con-
comitant ingestion of ethanol, disruption of routine, and
pollinosis [197]. For hymenoptera venom anaphylaxis,
some contributing factors for increased severity have
been identified, including elevated baseline tryptase con-
centrations, older age, absence of urticaria and angio-
edema during anaphylaxis, and symptom onset within
5 min after a sting [211]. Due to the climatic conditions,
the Tropics favors insect living and therefore reactions
to stings are more likely to occur in these areas of the
world.
Anaphylaxis from hidden food allergens
Associated with the poor hygienic conditions prevalent
in tropical countries, allergic reactions to allergens hid-
den in the foods are more common in the Tropics. An
example is the atypical anaphylaxis induced by the inges-
tion of mite-contaminated foods (oral mite anaphylaxis
[OMA], pancake syndrome) that has received increased
attention in recent years [212]. Climatic conditions in
the Tropics, with high temperatures and humidity, are
favorable for mite growth, determining easier contamin-
ation of foods, especially wheat or corn flours. Eventually
some atopic mite-sensitive patients will develop systemic
symptoms when exposed to mite allergens through the
oral route [213]. Improved sanitation and some prophy-
lactic measures have been proposed to decrease the risk
of OMA [212].
Anaphylaxis and helminths
Anaphylaxis may occur in persons infected with Echi-
nococcus granulosus, and especially when fluid from
the ruptured cysts is released into the circulation in
patients who produce specific IgE to the parasite.
Also, rare cases of anaphylaxis triggered by Taenia
solium and Ascaris lumbricoides have been published
[214]. Anisakis simplex present in raw or undercooked
fish can also cause anaphylaxis, and this is more fre-
quent in countries where the use of raw fish is com-
mon [215].
Anaphylaxis is under-recognized and undertreated
everywhere in the world. Also, emergency treatment of
reactions is deficient in many countries, with low rates
of utilization of epinephrine, and higher use of second-
level drugs such as corticosteroids and antihistamines.
For example, in the Latin American Online Survey on
anaphylaxis the rate of utilization of adrenaline was as
low as 34.6 to 37.3 % [198, 216], whereas for DIA it was
less than 30 % [207]. Educational campaigns for physi-
cians and patients should be encouraged in order to im-
prove the management and prevention of anaphylaxis
since pitfalls are common [217]. Referral to specialists in
allergology should be promoted for diagnostic orienta-
tion, and implementation of preventive measures that
include immunotherapy and immunomodulation.
In summary, risk factors for anaphylaxis in the Tropics
are patient’s age, high prevalence of asthma, abuse of
alcohol, recreational drugs and medications, drug self-
prescription, high rates of infections, stress from economic
and political instability, and the high concentration of envir-
onmental allergens (mites, pollens from abundant flora,
molds, insects), pollution, and the presence of hidden aller-
gens in the food.
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The impact of allergen sensitization on allergy symptoms
The relationship between allergen sensitization and allergic
symptoms has numerous aspects that are currently under
investigation. It is indeed one of the central interrogates of
Allergy. Although intuitively logical that the stronger the
sensitization the more probabilities of inducing symptoms,
the problem is more complex and includes the conjunction
of several predisposing and protecting factors related to the
environment and the genetic background. However, since
sensitization patterns, as well as other situations, are very
unique in the Tropics, their study could help understanding
the natural history of allergy and direct future research. In
the following three sections we present the type and effects
of sensitization on allergy symptoms under the particular
conditions of the Tropics.
Allergen sensitization and asthma symptoms
Sensitization to aeroallergens is an important feature of
atopic asthma and impacts on long-term management
which includes environmental control and allergen im-
munotherapy. Knowledge of the fauna and flora provides
information on relevant environmental allergen expos-
ure in the population. This is limited in the Tropics and
other parts of the world, where a complete catalogue of
clinically relevant allergens is missing. A World Atlas of
Aeroallergens has been developed by the World Allergy
Organization (WAO) to guide clinical efforts and research
in the field of aeroallergen sensitization. Here some par-
ticular characteristics of allergen sensitization in tropical/
subtropical regions are discussed.
Indoor Allergens
Numerous population and clinic-based cross sectional
studies have shown that sensitization to indoor aeroal-
lergens is significantly associated with childhood
asthma in the tropical region of all continents [58, 59,
110–113, 115, 218–237]; summarized in Additional
file 3: Table S3. House dust mites are by far the most
predominant allergen sources in the Tropics where
populations are perennially exposed, mainly to B. tro-
picalis and D. pteronyssinus [238]. Since it thrives in
warm and humid climates, B. tropicalis is an important al-
lergen in tropical and subtropical regions [13, 59, 239–241].
The HDM fauna in Los Baños, Laguna, Philippines in-
cluded 32 species of mites belonging to 7 families. B. tropi-
calis (265 mites/g of dust in 87 % of households) and D.
farinae (71 mites/g of dust in 58 % of households) were the
most prevalent and abundant species [242]. Samples of
house dust collected from 50 homes in El-Arish city, North
Sinai, Egypt, revealed that 34.6 % of the samples had mites
[243]. Blo t 5 allergen was detected in 34 out of 88 raw and
processed food samples including wheat, corn, rice, bean,
wheat and corn flour, cake, and rusk collected from retail
stores in Benha city in the Nile Delta of Egypt [241]. In
some tropical areas, the majority of the homes from mite
allergic patients with asthma and/or rhinitis present con-
centrations of group 1 allergens >10 μg/g of dust in at least
one site of the house [244–246]. Although sensitization to
B. tropicalis is very common, levels of B. tropicalis allergen
Blo t 5 have been consistently low in homes of allergic
patients in Brazil [247, 248]. It has been reported that
specific IgE antibodies to D. pteronyssinus correlate with
total serum IgE levels in atopic asthmatics suggesting that
they contribute to the IgE levels [249].
Sensitization to these two mite species is very prevalent
in children with asthma in tropical Asia, Central and
South America, and Africa, with rates as high as >90 % in
some studies. B. tropicalis expresses species specific aller-
gens that have little or no cross reactivity with Dermato-
phagoides spp. [250, 251]. In Singapore and Taiwan the
major allergens of D. pteronyssinus associated with child-
hood and adult asthma are Der p 1 and Der p 2, and for B
tropicalis, Blo t 5 [218, 252]. IgE response to Blo t 1 was
72 % for sera from patients with positive skin test to B.
tropicalis and cross-reactivity with D. pteronyssinus was
not detected [253]. Blo t 21, a 129-amino-acid protein, in
spite of sharing 39 % identity with Blo t 5, was found to be
a non-cross reactive major allergen [254]. These two com-
ponents have low IgE cross-reactivity with A. lumbricoides
antigens; which would therefore confer higher specificity
in serodiagnosis assays than the crude mite extract [255].
Although not involving children but mainly university
students in Singapore, Andiappan et al. reported that IgE
sensitization in asthma and allergic rhinitis was almost
exclusively to D. pteronyssinus and B. tropicalis [60]. More
than 80 % of the cohort was sensitized and the levels of
specific IgE were 8 to 30 times higher than those to other
non-HDM allergen included in the study (German
cockroach, cat and dog dander, Bermuda grass pollen,
and a panel of molds). The HDM specific IgE levels also
correlated with serum total IgE. The authors concluded
that the allergic response in airway allergy is dominated by
a single class of allergen source, dust mites. This is also an
exclusive feature of asthma and respiratory allergies in
urban populations of the Tropics. In comparison, assess-
ment of respiratory allergy in the temperate climates would
involve a panel of indoor and outdoor allergens, and correl-
ation of allergen specific IgE titers with total IgE levels
would only be at most weak [256].
Relatively high rates of sensitization to other dust mites,
such as Euroglyphus maynei, Angiostrongylus malaysiensis,
Sturnophagoides brasiliensis, Tyrophagus putrescentiae
[225], Lepidoglyphus destructor and Aleuroglyphus ovatus
[257] have been associated with asthma. A study in Quito
(Ecuador) detected large populations of house dust and
storage mite allergens in areas above 2500 m of altitude,
where humidity remains high year round. Positive skin
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prick tests (SPT) reactions to D. pteronyssinus, D. farinae,
B. tropicalis, L. destructor, T. putrescentiae, A. ovatus, A.
siro, and G. domesticus were obtained in 60.9, 56.8, 17.0,
19.3, 10.6, 15.8, 8.8 and 11.0 % of the patients, respectively
[258]. The prevalence of positive SPT to different mite spe-
cies was determined in asthmatic adults and children living
in seven cities of five Latin American countries.
Sensitization to D. pteronyssinus varied from 60.7 % in
Cartagena to 91.2 % in São Paulo and to B. tropicalis from
46.5 % in Mexico City to 93.7 % in São Paulo. In general,
skin sensitivity to storage mites was lower than to domestic
mites. Reactivity to mite allergens is very common in young
and adult asthmatics in Latin America, in areas both at sea
level and at high altitudes reinforcing preventive measures
in the treatment of asthmatics in Latin America [257]. Of
176 atopic patients from Caracas – Venezuela, sensitization
to D. pteronyssinus was present in 97.2 % of the patients
and sensitivity to B. tropicalis in 91.6 % [59].
The prevalence of sensitization to D. pteronyssinus, D.
farinae and B. tropicalis in 1500 Taiwanese primary
school children were 90.79, 88.24 and 84.63 %, respect-
ively [259]. In tropical Singapore, the most common mite
allergens recognized in atopic children were Der p 1
(64 %), Der p 2 (71 %), Blo t 5 (45 %), Blo t 7 (44 %), and
Blo t 21 (56 %) [57]. Among Malaysians, older children
had significantly higher sensitization rates to D. pteronyssi-
nus (63.3 % vs. 23.1 %) and B. tropicalis (63.2 % vs. 16.7 %)
compared to younger children [49]. A study from Kolkata,
India revealed SPT positivity rates to D. pteronyssinus
(75 %), B. tropicalis (72 %), and D. farinae (63.7 %) in
1079 asthmatic patient. The high sensitization rate to B.
tropicalis suggested a causal role in airway allergy [260].
D. pteronyssinus and B. tropicalis represented an import-
ant source of storage mite in Haikou, a tropical island in
Southern China, but D. farinae, L. destructor, and A. siro
allergens were found in very few environmental samples.
The sensitization of asthmatic children to D. farinae was
considered to represent cross-reactivity with D. pteronyssi-
nus and B. tropicalis [261].
In Africa, mite fauna followed the same patterns of
other tropical/subtropical regions. Sensitization to D.
pteronyssinus, D. farinae and B. tropicalis was found in
53.2, 49.8 and 47.8 % of patients enrolled in a cross-
sectional study in Yaounde, Cameroon in sub-Saharan
Africa [262]. In the same city, the Odds ratios (95 % CI)
for sensitization of a group of adolescents to D. pteronys-
sinus, D. farinae and B. tropicalis in relation with asthma
were 7.28 (3.75–14.15), 2.65 (1.27–5.45) and 3.23 (1.68–
6.21), respectively [263]. Sensitization to one or more
mite species was reported in 24 % of Cairene children
with allergic diseases; D. pteronyssinus and D. farinae
were the most common sensitizers [264].
Besides dust mites, sensitization to cockroach allergens
is the next common risk factor associated with asthma
in the Tropics [90, 110, 112, 115, 218, 220, 229, 230, 36].
The rates of sensitization to Periplaneta americana is
slightly higher than Blattella germanica in Asia and South
America when allergens of both sources were assessed
[110, 223, 225, 230]. However, data from Singapore and
south China (Guangdong) have shown that the majority of
asthmatics who were sensitized to cockroach were also
sensitized to house dust mites [60]. Cross inhibition stud-
ies using sera of subjects from south China suggests that
D. pteronyssinus was the primary sensitizer for cockroach
sensitization in their population. Discrepancy between the
frequency of IgE sensitization to cockroach and the level
of its allergens in house dust has been reported. Cross-
reactivity due to tropomyosin, present in mites, cockroach,
shrimp and helminths may be one explanation for this
finding in areas where they are common [227]. Cockroach
allergy is important in Brazil and other places of South
America, yet environmental levels of cockroach aller-
gens have been surprisingly low in several studies
[244, 265, 266]. The reasons for this finding are not
completely understood. Skin test reactivity may be due to
IgE responses to cross-reactive allergens in mites [266].
Skin test to at least one cockroach extract was positive
in 83.1 % of atopic patients from Caracas, Venezuela
[59]. In Thailand, the incidence of cockroach allergy by
skin testing using crude extract ranged from 41 to 77.5 %
[267, 268]. The results of IgE-immunoblotting have shown
that 3 of 18 (16.7 %) allergic sera gave a positive reaction to
the native troponin-T preparation of P. americana implying
the role of this muscular regulated protein component as a
minor allergen in Thais [269]. Cockroach allergens were de-
tected in 93 % of households in Guangzhou city, southern
China, and were higher in living room than in bedding
samples [270].
Cockroach sensitization was detected in 43 out of 51
(84 %) asthmatic Egyptian children from Cairo city,
seven of them with high specific antibody response
[271]. In Lagos, Nigeria, 44.6 % of a group of asthmatic
patients had positive skin tests to cockroach allergen
compared to 9 % of the control subjects [272]. SPT for
B. germanica was positive in 47 (25.5 %) patients from
Yaounde, Cameroon [273]. In the South African Free
State, 38 % of a group of allergic rhinitis patients were
sensitized to B. germanica as tested by ImmunoCap
[274]. Sensitization to cockroach allergens was an inde-
pendent risk factor for asthma in Ghanaian children on
multivariate analysis (OR, 4.9; 95 % CI, 1.3–18.6) [115].
Inhalant allergy to insects other than cockroaches is
also present in the Tropics; sensitization has been re-
ported to the mayfly, housefly, caddis fly, moth and ant
[275]. The housefly (Musca domestica) was found to be
an important allergen in children with asthma in Northern
India; the sensitization rate was 37.6 % [276]. A high fre-
quency of sensitization to a silkworm moth (Bombyx mori)
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was observed in atopic children and adolescents with re-
spiratory allergies from the city of Curitiba, state of Paraná,
Brazil. The extract prepared from the wings of this moth
species was effective in demonstrating this sensitivity
[277]. The major allergen of B. mori larvae (Bom m 1)
is constituted by arginine kinase protein and displays
cross-reactivity with cockroach arginine kinase. There
is also evidence suggesting that mosquitoes could be in-
ducers of respiratory allergy [278]. Finally, anemophilous
indoor fungi in tropical regions have consistently deter-
mined a low degree of IgE sensitization in respiratory
allergic patients [279, 280].
Outdoor allergens
Sensitization to outdoor allergens (Additional file 3:
Table S3), such as pollens and molds, has been reported
in tropical environments; however, rates do not reach
the levels observed in patients with seasonal asthma and
allergic rhinitis in temperate climates. This could be due
to lack of exposure, but limited knowledge about the na-
tive flora should also be considered. Although numerous
studies have described tropical flora, the information
about the allergenic properties of pollens and molds is
scarce. Sensitizations to Oil Palm pollen (40 %) and
Resam fern spores (34 %) in Singapore [226] were asso-
ciated with atopy. Similar but lower rates of sensitization
were reported in Indonesia [219] and Thailand [220].
The subtropical grasses Chloridoideae (e.g. Cynodon dac-
tylon; Bermuda grass) and Panicoideae (e.g. Paspalum
notatum; Bahia grass) species are abundant in regions of
Africa, India, Asia, Australia and the Americas [281]. In
Brazil, Lolium multiflorum, also known as Italian rye-grass,
is the main cause of pollen allergy [282]. However, other al-
lergenic grass species grow randomly in city suburbs and
on abandoned plots of land, such as Anthoxanthum odora-
tum (sweet vernal grass), Bermuda grass, Holcus lanatus
(common velvet grass), Paspalum notatum (Bahia grass)
and Bromus spp., among others [283].
Dolichandrone platycalyx, commonly known as Nile
trumpet tree, is believed to have originated in East Africa.
The tree mostly grows in tropical climates, but temperate
species are also found. D. platycalyx was the fourth most
common sensitizer after Parthenium hysterophorus, Proso-
pis juliflora, and Artemisia vulgaris in Karnataka state,
India. It was found to be a moderate pollen producer
[284]. Catharanthus roseus or periwinkle plants are widely
grown as garden plants in the Tropics and subtropics. In
an agricultural farm in the suburban zone of Calcutta,
India, C. roseus pollen was found to be almost perennial
with 3.6–5.4 % contribution to the pollen load. Positive
SPT reactions were detected in 29.8 % of 282 patients with
respiratory allergy [285]. IgE mediated hypersensitivity
varied from 4.40 to 13.20 % in Indian atopic subjects to
pollens of one or more species of Brassica, a source of
Rapeseed-mustard [286].
Caryota mitis is also a common plant in tropical and
subtropical areas. It produces large amounts of pollen,
which has great potential for allergenicity in the pollin-
ation season. A study from Singapore sought to investi-
gate the components of C. mitis pollen contributing to
human allergic diseases. Twelve out of 20 serum samples
positively reacted to recombinant CmProfilin, as shown
by Western blotting and ELISA [287]. Sensitization rates
to ragweed and Japanese hop in South Korean children
increased annually (ragweed, 2.2 % in 2000 and 2.8 % in
2002; Japanese hop, 1.4 % in 2000 and 1.9 % in 2002)
[288]. Children living in Changhua area of Taiwan had a
higher pollen sensitization rates (Bermuda grass, 17.2 %;
Timothy, 12.3 %; ragweed, 5.7 %) than cat or dog dander
sensitization rate [289]. Weeds are the most common
aeroallergens in Ahfaz, Khuzestan province, which is a
tropical region in Southwestern Iran. It represented the
most prevalent outdoor aeroallergen (89 %) followed by
tree and grasses [290]. Maize pollen extract was identified
as a potential aeroallergen in Iran belonging to group 13 of
allergen categories [291]. In some parts of Saudi Arabia,
species of P. juliflora have been introduced by the millions
as roadside ornamentation. SPT positivity ranged be-
tween 11 and 76.1 % in 4 sites in the country. Multiple
sensitivities to other pollen antigens were detected in all
patients. The level of airborne Prosopis pollen detected
in Gizan exceeded 90 grains m3 of air [292].
Fungi
In some tropical environments, such as Puerto Rico and
Saudi Arabia [293, 294], basidiospores are the predomin-
ant fungal particulates in the atmosphere However, their
contribution to allergic respiratory diseases has not been
extensively studied as has occurred with mitosporic fungi.
Sensitization rates to crude spore extracts of the basidio-
mycetes Ganoderma applanatum, Chlorophyllum molyb-
dites and Pleurotus ostreatus were reported in 30, 12 and
12 % of 33 allergy patients from Puerto Rico [295]. In
asthmatic children from the same country exposure to the
highest quartile of glucan, a component of the fungal cell
wall that is used as a marker of fungal exposure, was asso-
ciated with more visits to the emergency room (95 % CI
for adjusted odds ratio, 2.7–28.4; P < 0.001) [296]. In
Cartagena, Colombia, sensitization to Penicillium nota-
tum was 28.3 % in asthmatic patients in a study where
sensitization to house dust mites ranged between 54
and 74 % [297].
Helminths
In tropical regions the coexistence of allergic asthma
and helminthic infections (two Th2 biased immuno-
logic conditions) is well documented; therefore IgE
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sensitization to species-specific and cross-reacting hel-
minth antigens and its impact on allergy symptoms
should be analyzed and will be discussed in other sec-
tions of this review.
Sensitization to common food allergens
Food allergy (FA) is a good example of how nature, cul-
tural patterns and lifestyles influence the IgE responses
and allergic symptoms. Its occurs frequently in children
under three years of age (3–15 %), but also in older
people (6-8 %) [298]; although it seems that in the Tro-
pics the same pattern occurs, more cohort studies are
needed to evaluate the natural course of this problem.
Studies in North America and Europe suggest that in
children more than 90 % of reactions are induced by a
small group of foods, mainly egg and cow’s milk, while
in adults the fish and shrimp are more frequent. Soy,
wheat, tree nuts and peanuts are also a common in these
populations [299]. Recent studies in tropical and sub-
tropical regions in Asia, Africa and Latin America sug-
gest that other foods have equal or higher frequency of
sensitizations than previously described [65, 300, 301].
In addition, analyses of the role of anaphylaxis triggers
show that food is an important cause of severe allergic
reactions in Asia [302] and in Latin America [303], being
fruits primarily involved in tropical countries such as
Singapore, Mexico, and South of China.
Several surveys suggest that peanut allergy is less com-
mon in populations living in tropical regions of Asia
[302, 304]. Furthermore, the patterns of FA appear to be
different than those observed in temperate climates. For
example, shellfish allergy predominates in both children
and adults, with prevalence rates higher than those re-
ported in temperate countries [304, 305]. Besides genetic
and ethnic factors [306], these features of food allergy
are likely related to environmental immunomodulatory
factors as well as exposure to aeroallergens. The age of
introduction of foods is another factor that seems to be
important at least to peanut allergy [307] and could ex-
plain why this allergy is less common in some tropical
populations. However, cohort studies specially designed
to explore this aspect in the Tropics are still missing.
Food allergen sensitization has been evaluated in several
surveys but a direct comparison of data is difficult as the
clinical characteristics of subjects are heterogeneous.
However, in this section we analyze cross sectional or
case control studies focused on children with various
allergic conditions, such as AD, asthma and FA. Most of
the studies are from tropical and subtropical Asia
[114, 259, 279, 289, 308–317] and are summarized in
Additional file 4: Table S4.
In general, egg and/or cow milk are the predominant
allergens [318]; but there are exceptions. Sensitization to
shellfish such as shrimp/prawn and crab is also
common, especially in older children. For example, in
Hong Kong [309], Taipei [259], Malaysia [310] and
Singapore [311], sensitization to these allergen sources
was either ranked top or second to egg when school
aged children were surveyed. This high rate of
sensitization mirrors the relatively high rates of reported
shellfish allergy in the region [304] and the frequency of
cross reacting allergens from other sources. Tropomy-
osin has been the most often implicated as the cross
reactive allergen. This is supported indirectly by IgE in-
hibition studies using sera of Spanish shrimp allergic
subjects living in a warm and humid climate [319].
Sensitization to soy and wheat are the next frequently
reported allergens. Although not systematically studied
in the Tropics, IgE mediated soy allergy is perceived to be
less common compared to the frequency of sensitization
[320]. Similarly, wheat allergy appears to be uncommon,
with the exception of Thailand where severe wheat allergy
has been described [321]. The high rates of sensitization
to soy and wheat have not correlated with true allergy.
Unlike allergies to cow milk, egg and peanut, where high
levels of specific IgE are useful predictors of a positive
oral food challenge, soy and wheat specific IgE levels are
poor predictors of true allergy [322]. The sensitization
to soy and wheat observed in the Tropics and subtropics
is also likely to reflect this phenomenon. The high rates
of asymptomatic sensitization may be due to cross
reactive allergens, possibly cross reactive carbohydrate
determinants, which have poor correlation with clinical
allergy.
Although the prevalence of peanut allergy is relatively
low in the tropical region compared to temperate climates,
sensitization to peanut shows importance in some studies
from Hong Kong, Singapore and Brazil. This relative high
prevalence of peanut sensitization may be asymptomatic
and also associated with cross reactivity to environ-
mental allergens. A study involving Ghanaian school-
children showed that IgE sensitization to peanut (17 %
in the cohort) was associated with S. hematobium
infection and was not associated with clinical peanut
allergy [317]. The authors postulated that carbohy-
drate cross reactive determinants accounted for this
cross reactivity as skin prick test positivity and re-
ported adverse reactions to peanut were far lower than
sensitization detected by IgE testing, at 2 % and 1.5 %
respectively. In contrast, sensitization to Ara h 1 and
Ara h 2 major allergens was common in cases of true
peanut allergy in Singapore [323] and Thailand [324].
This profile is similar to that found in peanut allergic
subjects in the US [325]. In Ghana, a study of food
allergy in 1407 school children found that 11 % had
adverse reactions to foods but only fifty percent of
these children showed a positive SPT reaction mostly
directed against peanut and pineapple [326].
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In a review of FA literature in Latin America, 41 reports
were original contributions [66]. In Mexico City [327]
food sensitization as detected by skin tests was 31 %,
mainly in children up to 7 years of age. Foods commonly
involved were fish (12 %), milk (7.7 %) and seafood
(6.5 %). In general, frequency of sensitization to egg and
peanuts was lower than those reported in the US and
Europe [326, 328–332]. Naspitz et al. [333] used a unified
panel of foods for a case-control study in several cities of
Brazil; although no food was associated with specific
allergy, the presence of specific IgE was higher among
patients (79 %) than controls (25.8 %) and the most fre-
quent allergens were fish, eggs, cow milk, wheat and pea-
nuts. In Costa Rica, Soto Quirós et al. [334] evaluated
specific IgE (MAST system and Phadia) to 15 foods in 183
children with asthma and 275 controls. No significant dif-
ferences on sensitization were found between the two
populations. Sensitizing foods in asthmatics were fish
(60 %), mixed vegetables (58 %), almonds (54 %), garlic
(53 %), yeast (51 %), wheat (50 %), soybean (48 %), egg
(48 %), milk (43 %), peanuts (42 %), corn (40 %), onion
(38 %), orange (28 %) and cereal’s mixture (15 %). This
pattern was almost the same in controls.
In general, studies about FA are difficult to compare
due to differences in definitions and the food panels
tested [335, 336]. Recently, J Boye [65] did a review on
the epidemiology of FA in developing countries and
noted that the current data were inadequate to perform
a systematic review or meta-analysis. The same difficulty
was found during a systematic review conducted in Latin
America [66]. The heterogeneity of the trials and the
lack of uniformity in the foods tested within the same
study lead to significant errors when assigning the
weight of each report [337].
In summary, food sensitization is a relatively common
phenomenon among atopic subjects in the Tropics. This
review suggests that food allergy in the Tropics has
points in common with studies in other regions but also
distinctive features; especially in terms of the type of
food that causes sensitization. Studies with provocation
tests are required to confirm the clinical relevance of these
sensitizations in Latin America and Africa. Another urgent
need is to perform multicenter studies using the same
methodology and the same food panels, including a large
number of fruits, vegetables and other foods of each trop-
ical region [338].
Sensitization to pets
Ownership of pets is supposedly frequent in the Tropics
with subsequent exposure to their allergens. The most
common pets are cats and dogs; the main allergens are
Fel d 1 and Fel d 4 for cats [339] and Can f 1 and Can f 2
for dogs [340]. Controversy exists as to the implications
and significance of pet ownership with regards to pet
sensitization, and the development of atopic disorders
[341]. The prevalence of pet sensitization in tropical coun-
tries and the relationship between pet ownership and
atopic disease has not been described in detail. Here we
present and analyze data pertaining to pattern, prevalence
and significance of pet sensitization in children from trop-
ical regions. Eighteen studies [105–115, 221, 225, 233,
313, 334, 333] describing pet sensitization were found.
They are summarized in Additional file 5: Table S5. Thir-
teen were cross-sectional, almost all drawn from children
seen at outpatient clinics. Only three [111, 112, 233] com-
prised children from community schools. All studies fo-
cused on cat and/or dog sensitization, based on skin prick
tests, specific IgE assessed by ImmunoCap, RAST IgE
[334] or MAST pipetting [334].
The prevalence of sensitization to pets varied widely.
One report [111] describes the prevalence of cat
sensitization in children; 3.7 % in Hong Kong and 4.3 %
in Guangzhou, China. The authors included Beijing as a
third study site in a temperate region, noting that cat
sensitization rates were highest in this city. They also
found that cat sensitization was associated with current
wheeze in Guangzhou but not Hong Kong or Beijing;
and associated with bronchial hyperreactivity in Beijing,
but not in the other two cities. The remaining surveys
reported prevalence of pet sensitization in children with
asthma or other allergic disorders. Dog sensitization was
between 0 % of children with asthma in Thailand [221]
and Ghana [115] to as high as 33.9 % in children with
asthma in Singapore, aged 6–14 years [225]. Rates of cat
sensitization were also variable, ranging from 1.5 % in
Singapore [114] to 40 % of asthmatics in Hong Kong.
Sensitization to cat and dog dander occurred late in
childhood, at an average age of 8.9 years in the single
large cross-sectional study of children with allergic rhin-
itis in Singapore [105]. Cat sensitization was associated
with the diagnosis of asthma in Nigeria [233] and Hong
Kong [113], as well as more severe asthma in Mexico
[106]. Conversely, two studies did not find any associ-
ation of cat or dog sensitization with asthma [115, 334].
Dog sensitization in Costa Rica [112] was linked to ec-
zema. None of the studies examined the relationship
between pet ownership and pet sensitization, and most
of them found that dust mite sensitization was more
significant than any pet sensitization.
Since many factors may influence the pattern, prevalence
and significance of sensitization, a comparison between the
data from the Tropics and non-tropical countries is dubi-
ous, at least until larger, more robust studies in the Tropics
are conducted. For example, studies based on patients
attending specialist clinics introduce a selection bias into
the subjects recruited. Of the three cross-sectional popula-
tion studies (less likely of having selection bias) only one
examined the prevalence of pet sensitization [111]. There
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were no cohort studies; therefore, assessing the temporal
relationship between pet ownership, pet sensitization and
disease was not possible. Leung et al. [108] demonstrated a
correlation between cat or dog ownership and Fel d 1 levels
in mattresses, bedroom and living room. This was also
shown in other recent study in the Tropics which examined
the association between indoor allergen levels and pet own-
ership, and found an association between cat ownership
and level of Fel d1 in child care centers. However, the
authors did not examine other relevant variables, such as
pet sensitization or presence of allergic disease [342]. To
our knowledge, there are no other recent studies in the
Tropics that have looked at allergen levels, pet owner-
ship and impact on the individual’s health or pattern of
sensitization.
A study in rural Chilean children showed inconsistent
association between animal exposures and allergy. Con-
tact with dogs in the first year was a protective factor of
rhinitis (OR 0.47, 95 % CI 0.28–0.80), but contact with
poultry and cats early in life increased the risk of rhinitis
(OR 1.42, 95 % CI 1.06–1.88; OR 1.82, 95 % CI 1.06–
3.14) [343]. Exposure to high levels of mouse allergen
was more frequent among non-recurrent wheezers
[248]. A positive skin prick test was observed for cat epi-
thelium (28.7 %) and dog epithelium (21.3 %) in 94 chil-
dren from Palmas, Tocantins, Brazil [254]. In Southwest
Nigeria, positive skin tests to cat, cockroach, mango
blossom and mouse epithelium were more frequent in
asthmatics than in healthy controls, especially in the
rural communities [233].
Caution should be taken in reporting sensitization to
cat in tropical areas endemic for parasites, as they can
induce anti-α-gal antibodies that cause false positive
binding to the α-gal moiety of the cat allergen, Fel d 5.
This means that tests suggestive of positive IgE to cat
may not truly reflect cat sensitization; Arkestal et al.
[344] demonstrated this in parasite-infected patients in
Africa who did not have cat allergy. Given that Fel d 1
is the major cat allergen in most of these patients,
component-resolved testing to Fel d 1 may be necessary
to avoid this diagnostic confusion in patients from
parasite-endemic regions.
In summary, given the inconclusive data on pet
sensitization in the Tropics, further studies are
needed. Large, well-designed birth cohorts for asses-
sing sensitization to various pets, and relate these to
the specific socio demographic factors, patient comor-
bidities, pet ownership and level of exposure, are
needed to improve our understanding of the role of
pets in allergic disorders.
Birth cohorts exploring early sensitization in the Tropics
Birth cohort studies are valuable strategies to analyze
early sensitization in humans. Concerning asthma,
more than 130 studies have been started around the
world in the last 30 years [345]; however, few have
been done in the Tropics [248, 346]. Birth cohort
results about early sensitization, risk factors and its
relationship with atopic disorders in the Tropics are
described below.
Latin America
Most information about early sensitization in the Tro-
pics derives from the FRAAT birth cohort, a follow-up
of ~300 children living in underprivileged urban neigh-
borhoods in the Caribbean coast of Colombia [46]. The
genetic background of this population resulted from
admixture between Native Americans, Africans and
Spaniards [347]. Cord blood (CB) IgE was the earliest
time point analyzed in this study. High CB total IgE was
positively associated with later sensitization, a common
finding in studies from temperate countries [348]. In
contrast to other latitudes where high total CB IgE has
been found associated with atopy-related phenotypes
[349, 350], this condition was protective from recurrent
wheezing in this cohort, replicating an observation from
Sunyer et al. in Tanzanian children [351]. Compared to
other latitudes allergen sensitization rates in this cohort
were high in the first years of life [248, 352, 353], being
B. tropicalis the main sensitizer. Interestingly, total and
specific IgE increased rapidly during early life and
sensitization at 3 years old almost reached the propor-
tion observed in adults. Most important risk factors for
positivity to B. tropicalis were poverty/unhygienic indi-
cators which could be related to helminth infections.
This cohort has a low burden of ascariasis, a condition
that may potentiate Th2 responses through various
mechanisms including cross-reactivity with HDM aller-
gens [354]. Although detection rate of soil-transmitted
helminthiasis by stool examination was low, it was ob-
served by IgE serology that half of the cohort was immu-
nized to Asc s 1 (a nematode specific marker), which is
indicative of frequent parasite exposure at this period of
life in this population [355].
ECUAVIDA is the largest birth cohort study in Latin
America. Ethnicity of the study population has been re-
ported as Mestizos (90 %), Afro- Ecuadorians (7 %) and
Amerindians (3 %) [356]. Preliminary data presented in
the cohort indicated that SPT responsiveness to at least
one allergen was 17.1 % at three years old; being Dermato-
phagoides spp. the most frequent sensitizer. Sensitization
to food allergens, fungi or grass was scarce. This study in-
volves children from a rural community in Esmeraldas
(Ecuador) wherein, at least 29 % of infants have been in-
fected with STH at 2 years old [48]. Unfortunately, in
ECUAVIDA the IgE response to B. tropicalis has not been
evaluated; therefore, positive cases of sensitization could
be missed. The relationship between allergen levels and
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early IgE responses has not been fully evaluated in Latin
American birth cohorts; however, Rullo et al. showed
that most children in their cohort were exposed to a
high load of mite allergens (2 μg/G of Der p 1 in mat-
tress). A positive association with sensitization was not
reported; instead, they found no statistical association
between allergen levels and recurrent wheezing [248].
Asia
GUSTO birth cohort is currently evaluating the natural
history of allergic diseases in Singaporean population
[357]. Cumulative prevalence of rhinitis was 32 % in the
first 18 months of life; a high rate in comparison with
cohorts from other latitudes [358]. Low income, eczema
and familiar history of atopic symptoms were detected
as risk factors for recurrent/prolonged rhinitis. As de-
tected by SPT, only 20 % of cases were sensitized to an
aeroallergen, mostly HDM; however it was more fre-
quent among cases than controls. The PATCH study, in
Taiwanese population, revealed important information
about food allergen sensitization. At 1.5 years, positive
specific IgE levels to common food sensitizers were de-
tected in almost half of children, but declined with age.
Early sensitization to food components was associated
with AD, in contrast, to inhalant allergen sensitization
that was found as a risk factor for respiratory allergy [359].
In this cohort, vitamin D levels in pregnant mothers and
children (starting in cord blood serum) were measured;
high correlation was found among mother’s and cord
blood levels. Low maternal 25(OH) D levels were associ-
ated with allergic sensitization, AD, asthma in early child-
hood [360]. Another birth cohort from Taiwan also
explored the relationship between AD and sensitization,
finding egg white sensitization as a risk factor [361].
Accordingly, it seems that in industrialized countries from
tropical/sub-tropical Asia the relationship between
sensitization and allergic disorders have similarities
with other latitudes. Another Asian cohort investigated
a very different scenario to the previous mentioned
cohorts. It enrolled pregnant mothers and their subse-
quently born children living in endemic villages for
filarial (W. bancrofti) and STH in Indonesia. At 4 years
old of follow-up, high rates of HDM and cockroach
sensitization were found by IgE serology, but not by
SPT. Sensitization to food allergens was rare. Interest-
ingly, there were found negative associations of filarial
infection as well as poverty indicators with child SPT,
but not with positive serum IgE [346]. Relationship of
sensitization with atopic disorders was not determined.
Africa
The Butajira Ethiopian cohort explored sensitization at
three years old by SPT with cockroach and D. pteronys-
sinus extract. Overall sensitization rate was low (8.7 %)
and unrelated to the presence of allergic manifestation
at three years old. Der p 1 or Bla g 1 levels, as well as
parental history of allergy were not associated with allergic
symptoms or sensitization in children [234]. At a later
point, incident cases of sensitization at 5 years old were
significantly associated with AD or rhinitis, but no wheeze
[362]. Data from this cohort revealed other important fac-
tors that may protect or increase the risk of sensitization
and allergic disorders. Helicobacter pylori infection (at age
5) was inversely associated with all allergic outcomes at
age 5 except wheeze and reached statistical significance
for sensitization – an effect observed only as a trend at
3 years [234, 362]. Use of paracetamol was associated with
wheeze, AD and sensitization [363], a previous finding in
cross-sectional studies from temperate countries [364].
As observed in adults, HDM are the most important
sensitizers in early life; meanwhile, responsiveness to food
allergens is rare [346]. Sensitization to common airborne al-
lergenic sources, determined by specific IgE, is actually
higher than in temperate countries [13, 346]. However,
when assessed by SPT, lower rates are found [355]. Poverty
conditions increase the risk of helminthiases as well as early
total and specific IgE production [13, 346], but they are also
protective from a positive SPT [346]. In summary, birth co-
horts for studying the natural history of allergy in the Tro-
pics are very few and just starting; however, they have
provided important information about the influence of par-
ticular risk factors, mainly helminth and HDM exposure,
on early sensitization.
The role of mite exposure
Mite allergy is a worldwide problem and in the context
of the Tropics it is probably the main cause of sensitization
and symptoms. Although it is currently accepted that mite
allergens cause respiratory and other symptoms, a lot
of work remains to be done regarding the patterns of
sensitization to purified allergens, their relationship
with specific symptoms, and the immunogenetics of the
IgE response. Why mite components are so allergenic
is a fundamental unresolved question that belongs to
the general theoretical problem of allergenicity. In the
Tropics, this and other questions have to be analyzed
in the context of perennial mite exposure, the immuno-
modulatory (suppression and/or enhancement) influ-
ence of helminth infections, an existent biodiversity,
and probably specific human microbiota. This particular
scenario should provoke the interest of the scientific com-
munity worldwide as it represents a potential source of
new knowledge, as will be described in the following two
sections.
The high strength of mite specific IgE in the Tropics
HDM are the main risk factor for asthma in the Tro-
pics [62]. Some of the effects of mite exposure on IgE
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sensitization and asthma have been described above;
here and in the next section we present a more detailed
analysis of the relationships between mite exposure and
helminth infection on asthma. An interesting characteris-
tic of allergy in the Tropics is the high rate of sensitization
to HDM allergens and the high strength of the specific
IgE response. This phenotype has been described in Asian
as well as Latin American tropical countries. In some
regions, perennial exposure may explain part of the hyper-
responsiveness to HDM allergens, in others where hel-
minthiases are still present, the cross reactivity between
HDM and Ascaris (and other helminth) allergens also play
a role [62, 354, 365, 366]. Furthermore, there is experi-
mental and epidemiological evidence indicating that in-
fection with the helminth A. lumbricoides induces a
nonspecific boosting of the IgE response to mite aller-
gens [367–369]. Genetic factors are less studied but in
some populations with important African ancestry,
genetic variants have been associated with high total IgE
levels and asthma [347, 370–372]. In addition, the num-
ber of allergen sources sensitizing asthmatic patients in
tropical zone seems to be low and restricted mainly to
HDM [60]. The clinical impact of this hyperresponsive-
ness to mite allergens is partially supported by the great
success of mite specific immunotherapy [373–378]; in
addition, there is epidemiological evidence of relation-
ship between sensitization and asthma and rhinitis
[297] and also provocation tests using mite extracts
[379–381].
Tropical mite species with clinical impact
Numerous mite species have been described as the source
of allergens capable of sensitizing and inducing allergic
symptoms in genetically predisposed individuals. HDM
are commonly present in human dwellings and are espe-
cially abundant in mattresses, sofas, carpets, and blankets.
The most studied are D. pteronyssinus, D. farinae and B.
tropicalis (Fig. 3). In addition, E. maynei, D. microceras, D.
siboney, Gymnoglyphus longior, Lepidoglyphus destructor,
Glycyphagus domesticus,Tyrophagus putrescentiae, Acarus
siro, Aleuroglyphus ovatus, Suidasia medanensis and
Chortoglyphus arcuatus have clinical relevance. Several
allergens have been characterized in most of these species
[382, 383]. Table 4 shows the species of mite that have
been described as allergenic in populations from the
Tropics. However, for some of them the IgE binding
capacity by serological or skin test remains to be
determined.
Prevalence and abundance
Latin America is one of the tropical regions with higher
prevalence of B. tropicalis and D. pteronyssinus. Thus,
these two species are the more common in Lima (Peru),
Juiz de Fora (Brazil) [384–386], Cartagena and Santa
Marta (Colombia) [386, 387] and Caracas (Venezuela)
[388], with preponderance of B. tropicalis in some cities.
In Central America, same species are very prevalent; in
Puerto Rico D. pteronyssinus and B. tropicalis are the
most prevalent followed by D. farinae and D. siboney
Fig. 3 Research activities on HDM B. tropicalis and the genus Dermatophagoides, as detected by number of publications. Data source:
Pubmed (until Jun 2014)
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[389]. In San José de Costa Rica, B. tropicalis is the most
frequent followed by C. arcuatus and D. pteronyssinus
[390]. In Cuba the more frequent are D. pteronyssinus,
B. tropicalis and D. siboney [391]. Other species with
low abundance in house dust samples are L. destructor,
S. medanensis and Cheyletus spp. [392]. Several species
of Blomia have been described, however B. tropicalis has
the greater occurrence and sensitization to other species
seem to be due to cross-reactivity [393, 394]. The mite
fauna of house dust from tropical regions of India,
Taiwan and Singapore is also dominated by D. pteronys-
sinus and B. tropicalis [260, 395], where important levels
of their allergens have been quantified in homes from
allergic patients. In contrast to temperate climates where
marked fluctuations of HDM allergen levels have been
reported, the tropical regions have few fluctuations be-
cause temperature and relative humidity is almost the
same the whole year [238].
Clinical impact
The frequency of sensitization to B. tropicalis, D. pteronyssi-
nus and D. farinae in asthmatics patients from different
cities of Latin America have been reported between 60 and
97 %. Sensitization to mites of low abundance such as C.
arcuatus, A. ovatus and L. destructor ranges from 21 to
71 % [257, 396, 397]. Although D. farinae is found in less
abundance than B. tropicalis and D. pteronyssinus,
sensitization to its allergens is similar to or greater than
those for D. pteronyssinus or B. tropicalis. D. siboney is
abundant in Cuba, where it has an important role as in-
ducer of allergic diseases. Frequencies of sensitization
higher than 80 % by skin test and higher than 95 % by
RAST were initially informed by Ferrandiz R et al.
[231]; recently, in a study based on skin test on 210
allergic patients, rates of sensitization were 78 % for D.
pteronyssinus, 51 % for D. siboney and 56 % for B. tropi-
calis [398]. The presence of D. siboney is also reported
in house dust samples from Puerto Rico [389] and
Colombia [386]. D. siboney have been found to cohabit
with B. tropicalis, D. pteronyssinus and D. farinae in
the tropical rain forest region of China, where dust
mite densities do not show significant variations across
seasons [399].
The frequency of sensitization to Suidasia medanensis
was 73 % in asthmatic allergic from Cartagena Colombia,
in a study where an important degree of cross-reactivity
between this species and B. tropicalis was found [400].
The genus Suidasia has been associated with anaphylaxis
by contaminated foods in Venezuela. Using provocation
tests Stanaland et al. [379] demonstrated that 83 % of B.
tropicalis sensitive patients in Florida (USA) had a positive
nasal challenge with B. tropicalis extract, indicating that
skin test is a good indicator of allergic symptoms after
inhalation of this allergen. In Brazil, 90 % of a group of
patients had positive nasal challenge to D. pteronyssinus
and 60 % to B. tropicalis [380]. In addition, patients who
were sensitized to D. pteronyssinus and B. tropicalis might
only react to one of them [381]. In a study that included
2206 children living in rural Taiwan a higher frequency of
sensitization to B. tropicalis than to D. pteronyssinus was
found, suggesting an important role of B. tropicalis in
wheezing children [401]. Studies in Cartagena, Colombia
and Florida, USA, showed that sensitization to these spe-
cies was associated with acute asthma both in adults [297]
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and children [402]. Several investigators have informed
about the importance of using B. tropicalis extract for a
better diagnosis of mite allergy and also recommend to
include it for an effective immunotherapy [250, 403]. Con-
sidering the great variety of mite species found in tropical
house dust, it is possible that other, minor sources of
allergens could be clinically relevant. For example, the
IgE reactivity to C. eruditus and C. malascencis have
been documented [382]. Also, frequency of sensitization to
Sturnophagoides brasilensis and Astroglycyphagus malay-
siensis has been reported between 50 and 70 % in allergic
patients from Singapore [225].
Cross-reactivity among mites
The IgE cross-reactivity between B. tropicalis and Der-
matophagoides is low to moderate [250, 404]. For
allergens such as Blo t 1 and Der p1, absence of cross-
reactivity has been documented [405]. Some allergic
populations show a species specific IgE response to-
ward Blo t 5 allergen, and the cross-reactivity between
group 5 allergens has been found low to moderate
when using whole recombinant allergens [251, 406].
This suggests that highly specific clinical reagents are
necessary for precise diagnosis and immunotherapeu-
tic treatment of sensitization to Group 5 mite aller-
gens. The presence of species specific IgE components
in B. tropicalis is illustrated by the study of 60 Taiwanese
patients, where two major allergenic components of B.
tropicalis, of about 14.3 and 27.3 kDa, were not inhibited
by D. pteronyssinus [407]. Employing ELISA inhibition
with sera from Colombian allergic patients 82 % of IgE
cross-reactivity between L. destructor and B. tropicalis ex-
tracts was demonstrated [404]. An important degree of
cross-reactivity was found by inhibition of immunoblot
using sera from Brazilian allergic patients, this study
suggested that Blo t 2 was the allergen responsible for the
cross-reactivity, since it is cross-reactive with the re-
combinant Lep d 2 of L. destructor [408]. RAST inhib-
ition studies using sera from asthmatic patients showed
high degree of cross-reactivity between B. tropicalis and
S. medanensis and suggested that B. tropicalis was the
main sensitizer [400].
The role of helminth infections
Helminthiases can influence allergic diseases by stimu-
lating or suppressing the immune response, depending
on the severity of the infection, which in turn is deter-
mined by host genetic susceptibility and the level of
exposure. A number of epidemiologic surveys suggest
that nowadays severe, chronic infections, with heavy
worm loads and polyparasitism are still present in rural
areas of the Tropics while intermittent and low intensity
infections occur mainly in urbanized areas, with A. lum-
bricoides and T. trichiura being the most common
parasites. As a consequence, helminthiasis is included
among the risk or protective factors for allergy in the
Tropics. During the last years it has become clear that
ascariasis may influence several aspects of allergy, such
as prevalence, diagnosis, severity and prevention. Since
an inverse prevalence rate between helminthiases and al-
lergy has been found it could provide insights into the
reasons of the high prevalence of allergy in urbanized
zones of the Tropics.
Theoretically all human infecting helminths can modify
type 2 immune responses including the allergic reactivity
but this has been more investigated in Schistosoma,
Ascaris, Filariae and Necator species. The putative
mechanisms underlying the connection between hel-
minthiases and increased allergic reactivity involve: (1)
induction of specific IgE antibodies against cross-
reactive allergens; (2) helminth-induced boosting of
specific IgE synthesis to bystander molecules; (3) mainten-
ance of selected B and T cell clones by repeated infections
and (4) perennial allergen exposure. In the next two sec-
tions we describe some of the most studied IgE binding
molecules from helminths as well as several components
with immunomodulatory properties, and discuss their po-
tential effects on the allergic responses of individuals living
in the Tropics. It is important to note that the IgE binding
property is not sufficient for being a clinically relevant
allergen and most of the IgE responses to helminth are
related to parasite immunity and not necessarily to allergic
reactions. In the following four sections we analyze the
several topics of helminthiases with demonstrated or po-
tential capacity to influencing allergic conditions in the
Tropics.
Helminth IgE binding components and their potential
role in allergy
Ascaris
A. lumbricoides is the most common soil-transmitted
nematode and compared to other helminth species is
very allergenic. Several epidemiological surveys have
found that ascariasis is a risk factor for asthma and
atopy and that IgE response to Ascaris allergens is more
frequent and stronger in mite-sensitized allergic patients.
A number of IgE binding components in the Ascaris ex-
tract have been detected by human sera [365], but only
three allergens are officially accepted by the WHO/IUIS
Allergen Nomenclature Sub-Committee: tropomyosin
(Asc l 3), glutathione transferase (GST, Asc l 13) and the
nematode polyprotein ABA-1 (Asc s 1). Tropomyosin, a
well-recognized pan-allergen, is involved in Ascaris-
HDM cross-reactivity, which is explained by the high
degree of structural homology between Asc l 3 and
HDM tropomyosins [365, 409]. Specific IgE levels to Asc
l 3 are significantly higher in asthmatic patients com-
pared to healthy controls and suggest that it may be a
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risk factor for asthma symptoms in the Tropics [62].
The cross reactivity between Ascaris and HDM tropo-
myosins is one of the mechanisms explaining the en-
hanced IgE responses to tropomyosins in asthmatic
patients living in the Tropics (reviewed in [410]). It has
been proposed that patients predisposed to asthma, with
a strong pro-Th2 genetic background, early age paras-
ited, suffering several re-infections and permanently
exposed to mite allergens probably have a stronger IgE
responses to allergens and more severe clinical symp-
toms [411, 56]. The pseudocelomic fluid of Ascaris con-
tains abundant amounts of the nematode polyprotein
ABA-1 (Asc s 1). In humans, the IgE and IgG responses
to ABA-1 has been associated with protection [412]
rather than allergy symptoms, and no association has
been found between IgE sensitization to ABA-1 and
asthma. Indeed, ABA-1 is a nematode specific antigen,
although present in other nematodes, it is not cross-
reactive with any of the B. tropicalis or D. pteronyssinus
allergens and is considered a nematode specific infection
marker [365]. The frequency of IgE reactivity to Asc l 13
is low (<20 %) but these molecules exists as isoforms
and may be clinically relevant in cases where there is
also sensitization to mite GSTs [413]. The allergenic
cross reactivity between Ascaris and HDM GSTs is sug-
gested by the structural homology between Asc l 13 and
allergenic GSTs in cockroach (Bla g 5) and HDM (Der p
8 and Blo t 8) however more studies are needed to prove
this. The additional discovery of allergenic properties of
Asc l 13 may explain why the frequency of IgE
sensitization to invertebrate GSTs is higher in the Tro-
pics than in populations living in temperate areas [414].
Filariae
IgE binding components have been described in Brugia
malayi and Onchocerca volvulus. A homologue of gamma-
glutamyl transpeptidase is a potent allergen of B. malayi,
involved in tropical pulmonary eosinophilia (TPE) and the
induction of antibodies against the pulmonary epithelium.
IgE levels to this molecule are significantly elevated in pa-
tients with TPE and possibly induce resistance to the infec-
tion [415]. Tissue-invasive filarial infection increased the
serological prevalence of IgE against HDM and cockroach,
but not against timothy grass [366], probably due to the
presence of tropomyosins [416]. Filarial GSTs are also
recognized by IgE of infected patients; and comparative
molecular studies between cockroach GST (Bla g 5) and W.
bancrofti GST revealed that filarial infected subjects show
IgE reactivity to both molecules [417]. Other filarial IgE
binding components include the aspartic proteinase inhibi-
tor Bm33 [418] and a fatty acid binding protein (BmAl-1)
that seems to be specific and conserved in filariids and
potentially allergenic [419]. The allergenic potential of
filarial cystatin has been evaluated in a murine model
but further studies in humans are needed [420].
Schistosoma
A group of proteins with orthologues in bee venoms,
and thereby called Venom-Allergen-Like (VALs) are
secreted during Schistosoma lifecycle [421]; among them
SmVAL from S. mansoni is a strong inducer of human
IgE. Some SmVALs are being proposed as vaccine candi-
dates; however, their allergenic effects remain to be fur-
ther explored [422]. Studies in mice models revealed
that challenge with SmVAL4 increases the number of
cells in the bronchoalveolar fluid, mainly eosinophils, in-
duces dense peribronchiolar infiltrate, increases specific
IgE levels and positive responses as detected by passive
cutaneous anaphylaxis [423]. Other Schistosoma spp. IgE
binding components are the tegumental allergen-like
(TAL) proteins. Sm22.6 (SmTAL1) as well as Sj22.6 and
Sh22.6 belong to this group. All induce IgE in infected
humans and the IgE response to TAL1 is associated with
resistance to re-infections [424–426].
Necator
There are two major N. americanus components that in-
duce specific IgE antibodies: NaASP2 and NaCalreticu-
lin. The first shares structural homology with the family
PR1 (Pathogenesis related Proteins 1). High levels of IgE
to NaASP2 is associated with low infection burden in
human populations living in endemic regions [427].
Clinical trials evaluating vaccine candidates for N. amer-
icanus revealed that NaASP2 induced IgG4 antibodies
[428] but in some individuals triggered generalized urti-
caria. Mean IgE levels to NaASP2 were 21 times higher
in subjects with urticaria compared to those without
symptoms [429]. Nacal1 binds IgE in all subjects with
detectable antibodies to the Necator extract [430] and
induced basophil degranulation and histamine release in
infected subjects from Madang, New Guinea [431].
Toxocara
Human specific IgE antibodies detect several components
in the excretory-secretory products of T. canis [432]. The
infection with Toxocara exacerbates allergic reactivity to
ovoalbumin in a murine model, and increases expression of
IL-4 in the lungs [433]; in addition, several epidemiological
studies have shown positive association between seroposi-
tivity to Toxocara and asthma. Although toxocariasis oc-
curs worldwide, it is more frequent in developing tropical
regions and its effects on allergen reactivity vary depending
on the context of the infection. In some areas toxocariasis
is associated with increased markers of Th2 immune re-
sponse and IgE sensitization to aeroallergens but also with
suppression of hypersensitivity reactions in skin [434, 435].
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Anisakis
Allergic symptoms are the most known effects of anisa-
kiasis. Anisakis typica is common in the Tropics and
Anisakis simplex in the northern hemisphere. Officially
recognized allergens are Ani s 1 to Ani s 14, being Ani s
1 the major allergen [436]. This molecule induces hyper-
sensitivity reactions in skin tests and basophil degranula-
tion in individuals sensitized to Anisakis [437]. Ani s 2 is
the Anisakis paramyosin and is recognized by specific
IgE antibodies in 88 % of individuals sensitized to this
nematode [438]; together with Ani s 3 is considered a
helminth pan-allergen [439]. Ani s 3 is the Anisakis tropo-
myosin, which has IgE cross reactivity with tropomyosin
from HDM, cockroach and shrimp [440], although it is
not an important sensitizers among patients [437]. More
studies are needed to define the role of these and other
Anisakis allergens on the IgE responses to allergens from
non-parasitic sources.
In summary, depending on the presence of polypara-
sitism, the overlap in the antigenic composition between
HDM, Ascaris and other nematodes could elicit diverse
immune responses and modify the effects of helminth
allergens on allergic diseases in the Tropics.
Helminth immunomodulators influencing allergy symptoms
There is increasing interest about the immunomodulation
associated with chronic helminth infections, which in
some rural areas make the population more susceptible to
viral infections and jeopardize vaccination programs. The
idea that parasite infections protect from allergies is
mainly derived from the indirect observation that, in en-
demic populations, asthma prevalence is lower than in
high-income countries where parasites have been almost
eradicated [441]. Numerous contradictory epidemiologic
results have been published around this topic, but basic
research has shown that, independently of the effects at
the population level, helminths have immunomodulatory
components or induce host derived immunomodulatory
pathways that can influence the evolution of allergic
diseases. In vitro experiments evaluating the effects of
helminth on infected hosts point out a clear suppressive
effect of several helminth species on the immune re-
sponse. Larva, egg or somatic worm extracts as well as
purified natural or recombinant products have proven to
be excellent stimuli for IL-10 or TGF-beta production,
both anti-inflammatory cytokines. In murine models of
asthma or airway hypersensitivity, helminths or their
products induce different mechanisms that may amelior-
ate the allergic phenotype [442, 443]. There have been also
controversial clinical trials in humans suggesting that hel-
minth infections (used as treatment) can control allergy
symptoms, and the potential of this strategy has been crit-
ically analyzed [444]. A list of helminth immunomodula-
tors from different species is described in Table 5.
Several studies have shown that helminth infections
expand the number of regulatory T cells (Tregs) [445, 446].
Besides, natural thymus-derived Tregs, other circulating
population secreting IL-10 or TGF-β, have been identified
[446, 447]. Helminth induced Tregs have immunosupres-
sive properties on other T lymphocytes [448] through cyto-
kine secretion or cell-cell contact mechanisms (by means of
CTLA-4 and GITR) [449, 450]. Tregs can induce specific
hyporesponsiveness to helminth antigens but also to by-
stander allergens [451]. Helminth infections can also in-
duce regulatory B cells (Bregs) [452]. In mice, it was
shown that the suppressive activity of S. mansoni extracts
on airway allergic inflammation was dependent on IL-10
producing B cells, mostly found in the spleen marginal
zone. These cells were found to promote conversion of T
cells to a regulatory CD25+ Foxp3+ phenotype. Other cells
are also subject of immunosuppression, for example,
chronic ascariasis decreases basophil activation [453]. In-
duction of high levels of total IgE and IgG4 by helminths
may diminish the effector mechanisms of allergy, such as
histamine release by mast cells and basophils. In general,
more research is needed to define the extent of helminth-
induced immunomodulation and its effects on the allergic
responses during or after natural human infection, which
is known to be also associated to helminth-induced
immunostimulation.
Table 5 Some helminth immunomodulatory products
Name Helminth Effects
Cystatin A. vitae Inhibition of antigenic processing. Suppression of Th2 inflammation in airway hypersensitivity
models and Th1 driven responses in experimental colitis. Induction of IL-10 production.
ES-62 A. vitae Decreases inflammation in rheumatoid arthritis model through IL-17 blockage. Inhibition of
mast cell activation and allergic reactions in airway sensitization models.
TGF-beta like factor H. polygirus, B. malayi Inhibition of airway inflammation, possibly through binding to mammalian TGF-beta receptor.
SM-16 Schistosoma spp. Suppression of thioglycollate-induced peritoneal macrophage maturation. Prevention of classical
macrophage activation.
Galectin T. leonine Reduction of clinical manifestations of experimental colitis. Th1 and Th2 inhibition by increasing
IL-10 and TGF-B production.
PAS-1 A. suum Reduction of allergic responses in airway hypersensitivity models. It also increases IL-10 and
TGF-beta production
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Intestinal microbiota and parasites
In recent years it has become clear that the human
microbiota, in its different locations, plays an essential
role in the development and function of the immune and
other systems. In the Tropics, a particular relationship
emerges with potential repercussions on the general
physiology of humans which is the co-existence of bacter-
ial commensals and parasites in the intestine. The com-
position of human intestinal microbiota is determined by
several factors, most of them undefined. It is known that
competition for microbial nutrients, the immunomodula-
tor properties of some bacteria, the diet and the host in-
nate immune responses might play a role; however the
effects of helminth infections on microbiota composition
and the role of microbiota in helminth immunity and its
effects on allergy have been poorly analyzed. A brief com-
ment on this topic is very pertinent because the co-
evolutionary history of digestive system, immune system,
microbiota and helminth infections anticipates tight links
in between. Research on these topics has provided inter-
esting data that could lead to new interrogates regarding
the effects of helminthiases on the pathogenesis of allergic
diseases. First, several studies have found that alterations
of the microbiota promote Th2 responses, specific IgE to
mite allergens, asthma susceptibility and asthma severity
[454, 455]. Second, there is evidence that helminth infec-
tions increase asthma susceptibility [456] and severity
[232], Third, helminth infections can alter the microbiota
composition but the consequences on its immunomodula-
tory effects have not been evaluated. Therefore, it is pos-
sible that alterations of human intestinal microbiota by
helminth infections are an additional contribution to the
pro-allergic effects of helminthiases in the Tropics.
Genetics of helminthiases and allergy in the Tropics
Genetics of complex traits such as allergy and immunity
to helminths are matters of study worldwide, but it ac-
quires special interest in the Tropics because of the great
number of shared aspects between the allergic reaction
and the immune response to helminths. There is no
unique genetic background for people living in the Tro-
pics. Depending on their historical past, countries in this
zone are the results of diverse population admixtures
from most of the current world populations. African
ancestry is an important component of the genetic ad-
mixture in several tropical regions and some studies sug-
gest that this component predisposes to high levels of
total IgE and asthma, which could be the only known
risk at the population level; however, there are not
enough data supporting that this ancestry component
exerts influence in all genetic backgrounds. An advanta-
geous condition for studying the genetics of IgE re-
sponses in the Tropics is that extreme phenotypes such
as IgE hyperresponsiveness to allergens and helminth
components allow a better dissection of the genetic and
environmental influences. Epidemiological studies re-
vealed that in addition to exposure from the household,
genetic factors account for an important proportion of
the variation in worm loads [457–460]. A summary of
genes associated with the susceptibility to helminth in-
fections in humans [461–474] is presented in Table 6.
Common genes for helminth responses and allergic
phenotypes
Considering the overlap in biological pathways implicated
in the immune responses to helminths and allergens, it has
been hypothesized that some genetic variants influencing
the IgE response to helminths may also predispose to IgE
sensitization with non-parasitic allergens [470] or even pre-
dispose to allergic diseases [475, 476]. Peisong et al., found
an association between an asthma-related genetic variant of
STAT6 and Ascaris egg counts in China [466, 470]. The
5q31 locus is an example of a common locus for the sus-
ceptibility to helminthic infection and allergic diseases, as
shown by the linkage with the susceptibility to S. mansoni
and the genetic associations between IL13 polymorphisms
with the immune response to O. volvulus, implicating a
coding variant (Arg110Gln) that has been previously associ-
ated with asthma and other allergies [477, 478]. Genetic
variants in the gene encoding chitotriosidase (CHIT1) have
not only been associated with the response to filarial
infection but also with asthma [479, 480]. Shared gen-
etic variants between immune responses to helminth
and susceptibility to allergic diseases are not common
considering the great number of variants found associated
with asthma and other allergic diseases. Few studies have
evaluated simultaneously the effects of genetic variants on
the susceptibility to helminthiases and asthma in the same
population. Following this approach it was found that var-
iants of the gene TNFSF13B encoding for the cytokine B
Cell Activating Factor (BAFF) and other genes in the
13q33 locus were associated with the IgE response to As-
caris but not the IgE response to HDM allergens [473].
The tropical scenario, where helminth infections and aller-
gies are very frequent, is ideal for exploring the genetic
and evolutionary roots of both conditions.
Particular aspects of allergy diagnosis and management
in the Tropics
As expected, tropical conditions also affect diagnostic cri-
teria and management. Some of them are easy to under-
stand; for example, the predictive value of total IgE might
be limited by the polyclonal expansion of IgE producing B
lymphocytes induced by helminth infections. But others,
such as reagents for component resolved diagnosis (CRD)
or mite allergens avoidance require more studies consider-
ing the great variety and level of exposure to mite aller-
gens. In the following five sections we will discuss several
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Table 6 Genetic variants associated with the immune response to helminths
Gene Locus Product Variant Effect Helminth Population
IL10 1q31-q32 Interleukin 10 rs3024492 Allele C of rs3024498 was negatively associated
with helminth infection
Ascaris lumbricoides Brazil
CHIT1 1q32.1 Chitinase 1 chitotriosidase H allele: 24 bp duplication
in exon 10
Homozygotes HH low levels of chitotriosidase.
H allele over-represented in the infected group
Wuchereria bancrofti South India
- 2p21-p14 Unknown D2S2378 Linkage between the numbers of microfilariae
and markers at 2p21-p14
Onchocerca volvulus Ghana
TLR2 4q32 Toll receptor 2 −196 to −173 del Higher risk of asymptomatic filariasis Wuchereria bancrofti Thailand
+597 T > C
+1350 T > C
IL13 5q31 Interleukin 13 Arg110Gln Gln/Gln: Strong Th2 reactivity, low microfilarial number Onchocerca volvulus Guinea
−1055 C > T Less Ascaris burden Ascaris lumbricoides China
rs7719175 Haplotypes rs7719175T and rs1800925C
associated with high infection levels
Schistosoma haematobium Mali
rs1800925
MBL2 10q11 Mannose-binding lectin 2 Low –expressing MBL Increased prevalence of positive circulating
filarial antigen (CFA status)
Wuchereria bancrofti Tanzania
Defective C allele Three times more probability to be infected
with Filariae
STAT6 12q13 Signal transducer and
activator of transcription 6
Microsatellite in exon 1 Carriers of the short allele plus SNPs haplotypes
have lower levels of Ascaris infection
Ascaris lumbricoides China
5′UTR/3′UTR haplotypes
3′UTR SNP 4219 G/A Homozygotes GG have the lowest egg counts Ascaris lumbricoides China
- 13q33-34 Unknown D13S1265 D13S285 Linkage with egg counts of A. lumbricoides
in stool and total IgE levels
Ascaris lumbricoides Nepal
TNFSF13B 13q33 B Cell activating factor G3980 > C GG homozygotes have higher levels of IgG
to Ascaris
Ascaris lumbricoides Colombia















circumstances where conventional diagnostic tools and
management have limitations or particularities that should
be considered in clinical practice and future research in
the Tropics.
Usefulness of total IgE and other diagnostic tests
It is well known that patients with allergies, especially
asthma, have higher serum IgE levels compared to non-
allergic subjects [481, 482] but abnormally higher IgE
levels have also been described in a variety of diseases
such as helminthiases, primary and secondary immuno-
deficiencies, graft versus host disease, chronic infections
and neoplasms. Serum IgE levels, peripheral blood eo-
sinophilia and skin test reactivity to allergens have been
used to identify atopic individuals. The diagnostic value
of allergen specific IgE is accepted but the predictive
value of total serum IgE levels is controversial anywhere.
Helminthiases are frequent inducers of high serum total
IgE [483], therefore this test is not useful for diagnosing
asthma or other allergic disease in individual cases. Be-
cause of its non-specific nature [484, 485], total IgE has
been replaced by the specific IgE to allergens as a good
marker of both, atopy and allergic diseases. However,
there is an additional problem in the Tropics which is
the impact of cross-reactivity in the diagnosis of mite al-
lergy, the most important risk factor for asthma. Ascaris
cross-reactive allergens, such as tropomyosin and GST,
may influence mite allergy diagnosis when using the whole
mite extracts, as is routinely done in vitro and for skin
testing. Therefore, in the Tropics the use of complete mite
extracts for diagnosis could lead to false positive results.
Component resolved diagnosis, including mite and Ascaris
purified allergens, could help to resolve this problem.
Another limitation of serologic allergy diagnosis in
patients with helminthiases is the presence of the carbohy-
drate epitope galactose-α1,3-galactose (α-Gal), expressed in
non-primate mammalian proteins, such as the cat allergen
Fel d 5 (cat IgA). It has been reported that the diagnosis of
cat allergy may be impaired among parasited patients [344].
There are other reports suggesting that intestinal helminths
have α-gal [486], but immunochemical studies on Ascaris
extract show that deglycosylation treatment does not sig-
nificantly affect the specific IgE antibody binding to the
extract [365]. Further research is needed to confirm the
presence of this cross-reactive carbohydrate in Ascaris. It
has been reported that skin test reactivity to clinically rele-
vant allergens is low among children with chronic severe
helminthiases, including ascariasis [53], although the IgE
response to allergens can be demonstrated in those patients
using serological methods. This epidemiologic finding may
be not visible at the individual patient-physician level;
however, if sensitization to allergens is evaluated in these
communities using skin tests, false negative results will be
common, and this may enforce the opinion that not only
allergy symptoms but also allergen sensitization are infre-
quent in parasited populations. Allergists in the Tropics
have to follow different criteria for diagnosing allergic
diseases and other diseases known to have increased IgE
production. Total serum IgE determination for assessing
the suitability of a patient for anti-IgE treatment may be
difficult in clinical settings [487].
Component resolved diagnosis for mite allergy
Several studies have intended to define the minimum
number of components needed to replace mite extracts.
This has been achieved for D. pteronyssinus, with potential
clinical usefulness in temperate and tropical countries.
However, in the case of B. tropicalis more research, includ-
ing new recombinant allergens, is required to replace the
whole extract. In addition, a particular point in the Tropics
is the abundance and diversity of mites leading to frequent
and strong sensitizations to different species due to both,
co-sensitization and cross reactivity. This makes difficult
the selection of extracts for immunotherapy, a problem that
could be resolved if species specific components were
found. Currently there is no platform designed for CRD in
the Tropics, where more than 80 % of allergic patients are
sensitized to any of the HDM species B. tropicalis or D.
pteronyssinus [396]. Around 10 % of allergic patients are
mono-sensitized to B. tropicalis and a similar proportion is
detected for D. pteronyssinus by current diagnostic methods
[488], even though people are co-exposed to both species
[489]. Most of allergic patients, double-sensitized, receive
immunotherapy with an admixture of the two sources. It is
unknown in which extent one of the two preparations
is unnecessarily administered since cross-reactive com-
ponents are frequent sensitizers. Another potential
problem is the bias in diagnosis that causes IgE cross-
reactivity between HDM and helminth antigens that
frequently induces specific IgE production in the ex-
posed population [365, 490]. Therefore, IgE testing of
species-specific markers as well as cross-reactive mole-
cules could help to define the most appropriate reagents
for mite allergy immunotherapy in the Tropics.
Some attempts have been made to replace the HDM
extracts using recombinant components in the Tropics.
In Colombia, the combination of Der p 1, Der p 2 and
Der p 10 detected 93.5 % of the D. pteronyssinus positive
sera [491]. In Brazil, Blo t 5 and Blo t 21 detects 96.4 %
of the responders to the whole body extract [255]. In
Singapore, by testing 14 components from B. tropicalis,
Kidon et al. found that the combination of Blo t 5, Blo t
21 and Blo t 7 detected about 70 % of SPT positive pa-
tients. In the case of D. pteronyssinus among 14 allergens,
Der p 1 and Der p 2 identified approximately 78 % of D.
pteronyssinus extract responders. Inclusion of other aller-
gens did not increase the sensitivity of the battery. Regard-
ing the combination of allergens for selecting the
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appropriate extract (B. tropicalis vs. D. pteronyssinus) for
immunotherapy, it can be hypothesized that using Der p
1, Der p 2, Blo t 5 and Blo t 12 in different steps of the
diagnostic process could be a good approach.
Component resolved diagnosis for pollen and mold
allergy
Pollen sensitization profiles vary in different tropical
countries and are certainly different to those found in
more temperate regions. Regarding grass species, the
subtropical/tropical grasses of the Chloridoideae (e.g.
Cynodon dactylon; Bermuda grass) and Panicoideae (e.g.
Paspalum notatum; Bahia grass) species are abundant in
parts of Africa, India, Asia, Australia and the Americas
[281]. Patients sensitized to these species show partial
cross-inhibition of IgE reactivity by temperate grass
pollen allergens indicating the presence of species-specific
IgE binding sites in subtropical grass pollen allergens that
are not represented in temperate grass pollens. This
fact has important implications when designing allergen-
specific immunotherapy to subtropical grass pollen aller-
gens [492]. A study performed in Zimbabwe, central
Africa, revealed that compared to central European grass
pollen allergic patients, African patients did not recognize
Phl p1, Phl p 5 or Phl p 2 as major allergens, but a higher
recognition of Phl p4 was detected, possibly by a predom-
inant sensitization to Bermuda grass which preferentially
expresses species-specific allergens rather than cross-
reacting molecules. Specific IgE to profilin and to Bet v 2
was extremely prevalent, while Phl p 12 was much lower
[493]. A recent study has revealed an astonishing high
frequency of IgE sensitization to non-allergenic, grass
pollen–derived carbohydrate epitopes and the absence of
IgE reactivity to highly allergenic grass pollen protein al-
lergens in the Philippines, indicating that the local flora
consisting of tropical grasses does not induce clinically
relevant sensitizations [494].
A recent publication assessed the usefulness of a
multiplex allergen microarray in atopic patients from
Singapore. The authors suggest that this tool is not opti-
mal for general screening, especially in a population with
low rates of polysensitization and a dominant sensitizing
allergen (HDM), but propose that it may have a role if the
allergen molecule panel is adjusted to regional differences
[495]. Another relevant source of allergens in the Tropics
are molds, and indeed, allergic patients frequently display
mold sensitization [63, 496]. Nevertheless, component
resolved diagnosis in fungal allergy has been mainly lim-
ited to Alternaria and Aspergillus species, and know-
ledge in this area is still scarce [497]. These data
suggest that indeed there is a role for CRD in order to
define true sensitization to a specific pollen allergenic
source and to evaluate the role of certain panallergens
in the Tropics.
IgG/IgE ratio and allergy symptoms
IgG/IgE ratio is emerging as an important parameter in
clinical allergy. First it was noticed that the IgE responses to
diverse allergen sources was accompanied with IgG anti-
bodies to the same allergens [498]. Normal population had
mainly IgG while allergic subjects showed predominantly
IgE [499], suggesting an unknown physiologic role for IgG,
in relation to a non Th2 response. An important step to
understanding the role of IgG responses, especially IgG4,
has been the analysis of allergen specific immunotherapy
mechanisms. Several studies have shown that SIT-induced
IgG4 can act as blocking antibodies [500]. Furthermore,
the potential allergy-protective role of IgG4 antibodies
has been identified in food sensitized but clinically
tolerant individuals [501].
In the Tropics most research on this topic has been
performed around parasitic infections; however some
preliminary data on food allergy is available [502]. Despite
this, to date the exact value of measuring the IgG/IgE ratio
to predict the clinical response to a specific allergen re-
mains unclear and it is, therefore, not currently recom-
mended as a diagnostic tool [503]. A study in Brazil has
shown that D. pteronyssinus specific IgG4 is associated
with reduced levels of IgE to this mite, resulting in 35–51 %
inhibition of IgE reactivity in atopic patients, but no clinic-
ally relevant data were reported [504]. Also, in Brazilian
patients with AD, B. tropicalis-specific IgG4 was probably
induced by chronic exposure to this mite in the home en-
vironment [505]. In cat allergy, studies have shown that
high levels of IgG antibodies also provide a further marker
of cat allergen exposure among Japanese patients with
asthma [506]. Taken together, these data support the as-
sumption that IgG antibodies are markers of exposure, and
they do not allow inferring clinical reactivity in tropical
areas. However, it has been found that chronic infections
such as schistosomiasis and chronic exposure to laboratory
animals promote IgG4 antibodies that could prevent allergic
symptoms induced by the concurrent IgE-response
[507, 508]. Therefore, it is possible that parasite infec-
tions could modify a parameter of potential clinical
usefulness that is IgG4/IgE ratio. As in other places of
the world, this aspect should be further investigated in
the Tropics.
The effectiveness of allergen quantification and
avoidance
Allergen avoidance is a general recommendation in clinical
practice for reducing frequency of symptoms; even though
its effectiveness is not well documented. Also, it is still an
open question if HDM allergen avoidance is a good primary
prevention strategy since there is some evidence, mostly
derived from temperate countries, about a dose–response
relationship between HDM exposure and allergen
sensitization. Systematic reviews about this topic,
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including studies from all over the world, have con-
cluded that interventions to reduce HDM exposure do
not significantly improve asthma control [509, 510]. It
is of great importance to know how useful avoidance
measures in the Tropics could be, considering that the
climate predisposes to high HDM allergen levels in a
constant manner (no seasonal variations). However,
few studies have been done in tropical or sub-tropical
countries, most of them with small sample size. From
this limited data, positive results have been observed
with some control measures.
In Egypt, 106 HDM allergic asthmatic children were
allocated into one of four different intervention groups
for HDM avoidance (chemical, physical, both chemical
and physical or none). Physical measures included proper
ventilation practice, completely bed covering and cleaning
advice. Chemical interventions consisted of spraying car-
pets and bedding with tannic acid 3 % twice weekly. Sixteen
weeks later, all interventions, especially the combination of
both methods, reduced Der p 1 levels but not more than
20 % from baseline. The group for which physical control
measures were used showed significant improvement in all
outcomes. The control group (no intervention) also showed
reduction of clinical symptoms, although this was more
marked in physical intervention. Advantage of this study is
that they used simple and not expensive measure such as
HEPA filters [511]. Another study from Singapore evalu-
ated bed covers and HEPA filters as two control methods
to reduce HDM exposure in a small sample of asthmatic
children (n = 24). Bed covers, but not HEPA filters, were ef-
fective for reducing Der p 1 and Der f 1 levels but not sig-
nificantly associated with lung function improvement [512].
In addition, its efficacy lasted for only two months which
means that they must be washed or replaced. In conclusion,
although physical methods to reduce HDM exposure are
partially effective, cleaning advice and bed covers seems to
be recommendable to reduce allergic symptoms. Interven-
tion studies to identify the relationship between allergen
levels and development of allergic diseases have not been
performed in tropical countries. It is possible that conven-
tional cut-offs to define high level of exposure to HDM are
not applicable to tropical regions in terms of incremental
risk for allergy development.
Ongoing changes in lifestyle
Lifestyle changes are suspected to influence the increasing
frequency of allergic diseases worldwide [513]. Sedentary
and indoor lifestyles, changes in the diet and hygiene
improvement have repeatedly been associated with the
increasing trend of allergy. More recently biodiversity
loss and climate change [514, 515] have been added to
the long list of potential explanations. In the Tropics the
most significant environmental and lifestyle changes have
been related to urbanization. In addition to the changes
that urbanization brings everywhere, this process has im-
plied security risks when occur in association with extreme
poverty leading to changes in home design and in-
creased time indoors. The impact of these changes on
mite sensitization and respiratory allergy has not been
evaluated.
Unmet needs and perspectives
This review analyzed particularities of allergy in the Tro-
pics, revealing important areas that require further investi-
gation. Allergy training in tropical countries is out of the
scope of the present review but will be analyzed in depth in
a special document. Among the most important gaps is the
role of pollens and molds as risk factors for asthma and
rhinitis. This should be addressed in a collective effort to
obtain comparable results and to test native allergens.
Other topics that mandate further investigations include
the prevalence and characteristics of stinging insects allergy;
the prevalence and causes of Oral/Allergy syndrome; the
relationship between helminthiases and urticaria; the epi-
demiology of drug hypersensitivity; the importance of
tropomyosins in clinical practice of respiratory allergy; the
clinical relevant allergens that should be included for CRD;
the influence of helminthiases in the IgG/IgE ratio to com-
mon allergens; the prevalence of sensitization to alpha-gal
and other carbohydrates and their diagnostic impact and
the mechanisms underlying the effects of latitude and
urbanization. Given the limitations of mite exposure avoid-
ance in an environment where these organisms grow so
easily, mite specific immunotherapy in the Tropics also re-
quires further studies. Also, the search for helminth derived
immunomodulators that could compensate for the effect of
progressive decline of parasite infections should be stimu-
lated, bearing in mind the potential adverse side effects on
the immune responses to viral diseases. Genetic and epi-
genetic studies of atopy and allergy susceptibility could be
more informative in the unique environmental conditions
of the Tropics than in temperate climes. Since several re-
search groups focused in both clinical and basic sciences
are increasing in the new “New World”, the prospects for
the field of allergy are promising.
Conclusions
This review supports the idea that the field of allergy in
the Tropics has particularities that deserve special attention
from the scientific community and clinicians everywhere
because they strongly affect the natural history of common
allergic diseases. Defining epidemiological trends, risk fac-
tors and management possibilities will help numerous
patients living in the tropical zone; therefore they should be
part of specialty training programs in hospitals and univer-
sities. At the same time, this knowledge will help to better
understand the pathogenesis and evolution of allergic
diseases in temperate zones. We also noticed an emerging
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“allergy community” from several research centers in devel-
oping countries addressing fundamental and practical ques-
tions about the origin of allergy in tropical settings and
raising interesting hypotheses whose solutions will involve
both senior researchers as well as basic science and clinical
fellows in training.
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